Existing Annotations Review

Core Functions

The CORE molecular function of Bcl-xL (canonical isoform Q07817-1). Bcl-xL contains a BH3-binding groove that binds the BH3 domains of pro-apoptotic proteins including BAX, BAK, BAD, BIM, PUMA, and NOXA. This binding sequesters pro-apoptotic proteins at the mitochondrial outer membrane and prevents their activation of the apoptotic cascade. Structural studies have characterized the BH3-binding groove at atomic resolution (PMID:21199865, PMID:21639858). As established in the foundational paper PMID:8358789, bcl-xL inhibits cell death upon growth factor withdrawal. By preventing BAX/BAK pore formation at the MOM, Bcl-xL inhibits cytochrome c release and blocks apoptosis. CRITICAL ISOFORM NOTE: BCL2L1 produces two antagonistic isoforms through alternative splicing. Bcl-xL (Q07817-1, 233 AA) is ANTI-apoptotic (this core function). Bcl-xS (Q07817-2, 166 AA) lacks the BH1 and BH2 domains and is PRO-apoptotic.

Molecular Function:

BH3 domain binding

Directly Involved In:

negative regulation of apoptotic process

Cellular Locations:

mitochondrial outer membrane

References

GO_REF:0000002

Gene Ontology annotation through association of InterPro records with GO terms

GO_REF:0000033

Annotation inferences using phylogenetic trees

GO_REF:0000043

Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping

GO_REF:0000044

Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping, accompanied by conservative changes to GO terms applied by UniProt

GO_REF:0000107

Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara

GO_REF:0000108

Automatic assignment of GO terms using logical inference, based on on inter-ontology links

GO_REF:0000117

Electronic Gene Ontology annotations created by ARBA machine learning models

GO_REF:0000120

Combined Automated Annotation using Multiple IEA Methods

PMID:10365962

Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC.

PMID:10446169

Interaction of Alzheimer's presenilin-1 and presenilin-2 with Bcl-X(L). A potential role in modulating the threshold of cell death.

PMID:10837489

MCL-1S, a splicing variant of the antiapoptotic BCL-2 family member MCL-1, encodes a proapoptotic protein possessing only the BH3 domain.

PMID:11054413

Bcl-G, a novel pro-apoptotic member of the Bcl-2 family.

PMID:11060313

MAP-1, a novel proapoptotic protein containing a BH3-like motif that associates with Bax through its Bcl-2 homology domains.

PMID:11126360

A novel protein, RTN-XS, interacts with both Bcl-XL and Bcl-2 on endoplasmic reticulum and reduces their anti-apoptotic activity.

PMID:11278245

Bcl-B, a novel Bcl-2 family member that differentially binds and regulates Bax and Bak.

PMID:11463391

PUMA induces the rapid apoptosis of colorectal cancer cells.

PMID:11583631

BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis.

PMID:11714801

The association of Aiolos transcription factor and Bcl-xL is involved in the control of apoptosis.

PMID:11971963

c-Abl tyrosine kinase regulates the human Rad9 checkpoint protein in response to DNA damage.

PMID:12011449

Siva-1 binds to and inhibits BCL-X(L)-mediated protection against UV radiation-induced apoptosis.

PMID:12667443

p53 has a direct apoptogenic role at the mitochondria.

PMID:12815463

HSpin1, a transmembrane protein interacting with Bcl-2/Bcl-xL, induces a caspase-independent autophagic cell death.

PMID:14739602

The Siva-1 putative amphipathic helical region (SAH) is sufficient to bind to BCL-XL and sensitize cells to UV radiation induced apoptosis.

PMID:14752512

Human alphaA- and alphaB-crystallins bind to Bax and Bcl-X(S) to sequester their translocation during staurosporine-induced apoptosis.

PMID:15110758

FAST is a BCL-X(L)-associated mitochondrial protein.

PMID:16189514

Towards a proteome-scale map of the human protein-protein interaction network.

PMID:16608847

PUMA Dissociates Bax and Bcl-X(L) to induce apoptosis in colon cancer cells.

PMID:16697956

Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members.

PMID:17418785

Bcl-2 and Bcl-XL regulate proinflammatory caspase-1 activation by interaction with NALP1.

PMID:17428862

Induction of apoptosis by the severe acute respiratory syndrome coronavirus 7a protein is dependent on its interaction with the Bcl-XL protein.

PMID:17525735

ERK1/2-dependent phosphorylation of BimEL promotes its rapid dissociation from Mcl-1 and Bcl-xL.

PMID:19060904

An empirical framework for binary interactome mapping.

PMID:19180116

DAP-kinase-mediated phosphorylation on the BH3 domain of beclin 1 promotes dissociation of beclin 1 from Bcl-XL and induction of autophagy.

PMID:19427857

Transcriptomic and proteomic approach to studying SNX-2112-induced K562 cells apoptosis and anti-leukemia activity in K562-NOD/SCID mice.

PMID:20010695

Antagonism of Beclin 1-dependent autophagy by BCL-2 at the endoplasmic reticulum requires NAF-1.

PMID:20541605

RACK1 promotes Bax oligomerization and dissociates the interaction of Bax and Bcl-XL.

PMID:20673843

Regulation of cell death in human fetal and adult ovaries--role of Bok and Bcl-X(L).

PMID:21041309

BH3 domains other than Bim and Bid can directly activate Bax/Bak.

PMID:21081150

Pore-forming activity of BAD is regulated by specific phosphorylation and structural transitions of the C-terminal part.

PMID:21199865

Mutation to Bax beyond the BH3 domain disrupts interactions with pro-survival proteins and promotes apoptosis.

PMID:21639858

Structural changes in the BH3 domain of SOUL protein upon interaction with the anti-apoptotic protein Bcl-xL.

PMID:21840391

Bcl-xL phosphorylation at Ser49 by polo kinase 3 during cell cycle progression and checkpoints.

PMID:21856303

Protein oligomerization mediated by the transmembrane carboxyl terminal domain of Bcl-XL.

PMID:21988832

Toward an understanding of the protein interaction network of the human liver.

PMID:22498477

The anti-apoptotic Bcl-B protein inhibits BECN1-dependent autophagic cell death.

PMID:25241761

Using an in situ proximity ligation assay to systematically profile endogenous protein-protein interactions in a pathway network.

PMID:25296756

Plasminogen kringle 5 induces endothelial cell apoptosis by triggering a voltage-dependent anion channel 1 (VDAC1) positive feedback loop.

PMID:25416956

A proteome-scale map of the human interactome network.

PMID:26582200

Lifeguard Inhibits Fas Ligand-mediated Endoplasmic Reticulum-Calcium Release Mandatory for Apoptosis in Type II Apoptotic Cells.

PMID:26871637

Widespread Expansion of Protein Interaction Capabilities by Alternative Splicing.

PMID:27013495

The deubiquitinase Usp27x stabilizes the BH3-only protein Bim and enhances apoptosis.

PMID:27107012

Pooled-matrix protein interaction screens using Barcode Fusion Genetics.

PMID:29507230

Transmembrane E3 ligase RNF183 mediates ER stress-induced apoptosis by degrading Bcl-xL.

PMID:29997244

LuTHy: a double-readout bioluminescence-based two-hybrid technology for quantitative mapping of protein-protein interactions in mammalian cells.

PMID:31467278

Maximizing binary interactome mapping with a minimal number of assays.

PMID:31515488

Extensive disruption of protein interactions by genetic variants across the allele frequency spectrum in human populations.

PMID:31980649

Extensive rewiring of the EGFR network in colorectal cancer cells expressing transforming levels of KRAS(G13D).

PMID:32296183

A reference map of the human binary protein interactome.

PMID:32814053

Interactome Mapping Provides a Network of Neurodegenerative Disease Proteins and Uncovers Widespread Protein Aggregation in Affected Brains.

PMID:33961781

Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.

PMID:34800366

Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context.

PMID:35512704

Systematic discovery of mutation-directed neo-protein-protein interactions in cancer.

PMID:37398436

AI-guided pipeline for protein-protein interaction drug discovery identifies a SARS-CoV-2 inhibitor.

PMID:40205054

Multimodal cell maps as a foundation for structural and functional genomics.

PMID:7650367

Expression of Bcl-2, Bcl-x, and Bax after T cell activation and IL-2 withdrawal.

PMID:8358789

bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death.

PMID:9184696

The apoptosis and proliferation of SAC-activated B cells by IL-10 are associated with changes in Bcl-2, Bcl-xL, and Mcl-1 expression.

PMID:9305851

BH3 domain of BAD is required for heterodimerization with BCL-XL and pro-apoptotic activity.

PMID:9388232

Dimerization properties of human BAD. Identification of a BH-3 domain and analysis of its binding to mutant BCL-2 and BCL-XL proteins.

PMID:9393856

Bcl-xL regulates the membrane potential and volume homeostasis of mitochondria.

PMID:9843949

Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria.

Reactome:R-HSA-508162

BH3 only proteins associate with and inactivate anti-apoptotic BCL-XL

Reactome:R-HSA-6790025

Expression of BCL2, BCL2L1

Reactome:R-HSA-879201

Bcl-2 and Bcl-XL bind NLRP1

Reactome:R-HSA-9653595

pS181-S-Farn-Me KRAS4B binds BCL2L1

Reactome:R-HSA-9698026

FLT3 ITD- and STAT5-dependent BCL2L1 gene expression

Reactome:R-HSA-9704655

SARS-CoV-1 E binds BCL2L1

Reactome:R-HSA-9704692

SARS-CoV-1 7a binds BCL2L1

Reactome:R-HSA-9796043

NFE2L2 dependent BCL2L1 expression

file:human/BCL2L1/BCL2L1-deep-research-perplexity.md

Deep research report on BCL2L1

📚 Additional Documentation

Deep Research Perplexity

(BCL2L1-deep-research-perplexity.md)

provider: perplexity
model: sonar-deep-research
cached: false
start_time: '2026-01-18T23:50:52.171707'
end_time: '2026-01-18T23:52:48.941383'
duration_seconds: 116.77
template_file: templates/gene_research_go_focused.md
template_variables:
organism: human
gene_id: BCL2L1
gene_symbol: BCL2L1
uniprot_accession: Q07817
protein_description: 'RecName: Full=Bcl-2-like protein 1; Short=Bcl2-L-1; AltName:
Full=Apoptosis regulator Bcl-X;'
gene_info: Name=BCL2L1; Synonyms=BCL2L, BCLX;
organism_full: Homo sapiens (Human).
protein_family: Belongs to the Bcl-2 family. .
protein_domains: Apop_reg_BclX. (IPR013279); Bcl-2-like_sf. (IPR036834); Bcl-2_BH1-3.
(IPR046371); Bcl-2_fam. (IPR026298); Bcl2-like. (IPR002475)
provider_config:
timeout: 600
max_retries: 3
parameters:
allowed_domains: []
reasoning_effort: medium
search_domain_filter: []
return_citations: true
temperature: 0.0
citation_count: 54

Question

Gene Research for Functional Annotation

⚠️ CRITICAL: Gene/Protein Identification Context

BEFORE YOU BEGIN RESEARCH: You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

Target Gene/Protein Identity (from UniProt):

UniProt Accession: Q07817
Protein Description: RecName: Full=Bcl-2-like protein 1; Short=Bcl2-L-1; AltName: Full=Apoptosis regulator Bcl-X;
Gene Information: Name=BCL2L1; Synonyms=BCL2L, BCLX;
Organism (full): Homo sapiens (Human).
Protein Family: Belongs to the Bcl-2 family. .
Key Domains: Apop_reg_BclX. (IPR013279); Bcl-2-like_sf. (IPR036834); Bcl-2_BH1-3. (IPR046371); Bcl-2_fam. (IPR026298); Bcl2-like. (IPR002475)

MANDATORY VERIFICATION STEPS:

Check if the gene symbol "BCL2L1" matches the protein description above
Verify the organism is correct: Homo sapiens (Human).
Check if protein family/domains align with what you find in literature
If you find literature for a DIFFERENT gene with the same or similar symbol, STOP

If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE. Instead:
- State clearly: "The gene symbol 'BCL2L1' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

Research Target:

Please provide a comprehensive research report on the gene BCL2L1 (gene ID: BCL2L1, UniProt: Q07817) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Output

BCL2L1: A Comprehensive Analysis of Bcl-2-like Protein 1 Structure, Function, and Regulatory Mechanisms

BCL2L1, encoding the anti-apoptotic protein Bcl-xL and its pro-apoptotic isoform Bcl-xS, represents a critical regulator of cell survival and death decisions with multifaceted roles extending far beyond its canonical function in mitochondrial apoptosis.[4][16][22] Through alternative splicing, the BCL2L1 gene produces functionally antagonistic proteins that coordinate cellular responses to stress, regulate metabolic efficiency, and determine cell fate during development and disease.[1][4][13][29] Emerging evidence demonstrates that Bcl-xL not only inhibits apoptosis by sequestering pro-apoptotic effectors but also directly regulates mitochondrial bioenergetics, calcium homeostasis, and autophagy, establishing it as a hub protein integrating multiple cellular survival and death pathways.[11][21][37][40][42]

Molecular Structure and Domain Organization

Three-Dimensional Architecture and BH Domains

The BCL2L1 gene encodes a protein that belongs to the evolutionarily conserved Bcl-2 family, which is characterized by the presence of Bcl-2 homology (BH) domains that determine protein structure and function.[5][19][22] The three-dimensional structure of human Bcl-xL, first determined by both nuclear magnetic resonance (NMR) spectroscopy and X-ray crystallography, consists of eight α-helical regions designated as α1 through α8.[5][50] These helices are organized around a central hydrophobic core, creating a distinctive three-dimensional scaffold that establishes the protein's functional architecture.[5][50] The BH domains make essential contributions to the tertiary structure, with the BH1 and BH2 domains encompassing turn regions that link α4 to α5 and α7 to α8, respectively, while the BH3 domain is located entirely on α2.[5][50] The BH4 domain, positioned on α1, makes multiple stabilizing hydrophobic contacts with α2, α5, and α6, providing structural stability to the overall protein fold.[5][50]

A major structural feature of Bcl-xL is a large hydrophobic groove formed predominantly between helices α3 and α4, with α5 lining the groove's base, and residues from the BH2 and BH3 domains contributing additional structural elements.[5][50] This hydrophobic groove represents the primary interface through which Bcl-xL interacts with pro-apoptotic proteins containing BH3 domains, making it the critical binding site for regulating apoptotic signaling.[5][50][53] The groove demonstrates remarkable plasticity, undergoing significant conformational changes upon binding to different BH3-containing proteins, with α3 shifting away from ligands and often becoming less helical or disordered to varying degrees depending on the specific protein partner.[5][50]

C-Terminal Transmembrane Domain and Membrane Targeting

The Bcl-xL protein contains a single hydrophobic C-terminal transmembrane (TM) domain, typically spanning residues 210-226, that functions as a mitochondrial targeting signal rather than a simple membrane anchor.[8][33] Pioneering work by Kaufmann and colleagues demonstrated that Bcl-xL's transmembrane domain possesses specific targeting characteristics that distinguish it from Bcl-2, the founding member of the anti-apoptotic protein family.[8][33] The presence of at least two positively charged residues located at each side of the hydrophobic α-helix within Bcl-xL's transmembrane domain is critical for the protein's selective insertion into the mitochondrial outer membrane (MOM).[8] These charged residues act as a bona fide targeting signal for the MOM, being sufficient to address recombinant green fluorescent protein (GFP) to the mitochondria, in contrast to the transmembrane domain of Bcl-2, which addresses GFP to both mitochondrial and endoplasmic reticulum membranes.[8]

When inserted into the outer mitochondrial membrane, Bcl-xL adopts an Ncyto-Cin orientation, leaving the bulk of the polypeptide exposed to the cytosol where it can interact with other proteins.[33] This orientation is mechanistically distinct from Bcl-2, which associates with endoplasmic reticulum microsomes with comparatively lower affinity than its interaction with mitochondria.[33] Importantly, domain-swapping experiments revealed that transplanting the Bcl-xL transmembrane domain to Bcl-2 redirects Bcl-2 to the MOM, while transferring Bcl-2's transmembrane domain to Bcl-xL eliminates its selective mitochondrial targeting, directly demonstrating that the transmembrane domain sequences encode organelle specificity.[8]

Alternative Splicing and Isoform Generation

Bcl-xL and Bcl-xS: Antagonistic Functions from a Single Gene

One of the most remarkable features of BCL2L1 is its capacity to generate two functionally distinct protein isoforms through alternative splicing of exon 2.[4][13][26][29] The longer isoform, Bcl-xL (233 amino acids), functions as a potent anti-apoptotic protein, while the shorter isoform, Bcl-xS (166 amino acids), acts as a pro-apoptotic activator.[4][13][26][29] This alternative splicing event involves a choice between a distal and proximal 5′ splice site within exon 2, with the use of the distal site generating Bcl-xL and the proximal site producing Bcl-xS.[26] The two isoforms share identical N-terminal sequences up to amino acid 170 but diverge at this point, with Bcl-xL containing an additional 63 amino acids that include critical BH domain sequences, while Bcl-xS terminates with a unique sequence.[13][26][29]

The functional antagonism between these isoforms is direct and intimate: Bcl-xS can form heterodimers with Bcl-xL, directly binding to and inhibiting the anti-apoptotic protein through BH3 domain-mediated interactions.[26][29] By sequestering Bcl-xL, Bcl-xS prevents it from inhibiting pro-apoptotic effectors such as Bax and Bak, thereby liberating these proteins to promote mitochondrial outer membrane permeabilization (MOMP) and apoptosis.[26][29] The balance between Bcl-xL and Bcl-xS expression thus becomes a critical determinant of cellular susceptibility to apoptotic stimuli, with dysregulation of this ratio observed in cancer, diabetes, and other pathological conditions.[13][26][29]

Regulation of BCL-X Alternative Splicing

The alternative splicing of BCL-X is regulated by multiple splicing factors and signaling pathways, providing cell-type and stimulus-specific control over Bcl-xL and Bcl-xS ratios.[29] The serine/arginine-rich (SR) protein SRSF1 preferentially promotes the use of the distal 5′ splice site, resulting in increased Bcl-xL expression and enhanced apoptosis resistance.[29] SRSF1 activity is modulated through phosphorylation by kinases including NEK2 and SRPK1, both of which promote apoptosis resistance through increased Bcl-xL expression.[29] In contrast, SRSF9 binds to specific elements within the B3 region of Bcl-x pre-mRNA immediately upstream of the Bcl-xL donor site, shifting splicing toward the Bcl-xL 5′ splice site and upregulating anti-apoptotic Bcl-xL expression.[29]

The RNA-binding protein RBM4 acts as a splicing suppressor that antagonizes SRSF1 and upregulates the pro-apoptotic Bcl-xS isoform, functioning as a tumor suppressor in cancer contexts.[29] Expression levels of RBM4 are significantly decreased in cancer patients, and its levels correlate positively with improved survival, highlighting the therapeutic potential of modulating BCL-X splicing.[29] Transcription factors and cytokines also influence the Bcl-xL/Bcl-xS splicing ratio, integrating developmental and environmental cues with apoptotic sensitivity.[29] This multilayered regulation of BCL-X alternative splicing allows cells to dynamically adjust their apoptotic set point in response to diverse physiological and pathological signals.

Subcellular Localization and Mitochondrial Targeting

Primary Localization to the Outer Mitochondrial Membrane

While BCL-xL is classically characterized as an outer mitochondrial membrane protein where it exerts its primary anti-apoptotic function, recent evidence has revealed a more complex subcellular distribution that extends to multiple cellular compartments.[3][6][8][11] The selective targeting of Bcl-xL to the mitochondrial outer membrane (MOM) is mediated by the positively charged residues flanking its hydrophobic transmembrane domain, as discussed above.[8] In this location, Bcl-xL resides in close proximity to voltage-dependent anion channels (VDACs), membrane proteins that form pores in the outer mitochondrial membrane and regulate the exchange of metabolites and ions between the cytosol and the intermembrane space.[4][6][15]

Localization to Inner Mitochondrial Membrane and Matrix

Beyond its well-established outer membrane localization, Bcl-xL has been detected at inner mitochondrial membranes and even within the mitochondrial matrix in certain cell types and contexts.[3][6][11] Early evidence from immunoelectron microscopy demonstrated that Bcl-2, the prototype anti-apoptotic family member, localizes to the inner mitochondrial membrane (MIM), findings that were largely overlooked in subsequent research focused on outer membrane localization.[6] Subsequent investigations revealed that Bcl-xL protein also localizes to the MIM in hippocampal neurons, where it directly binds to the β-subunit of the F₁F₀ ATP synthase.[6][11][37][40] This inner membrane localization appears functionally important, as Bcl-xL binding to ATP synthase increases its activity and enables optimal ATP synthesis, indicating a role for this protein in regulating mitochondrial bioenergetics independent of its apoptotic functions.[6][11][37][40]

Electron microscopy and biochemical approaches have confirmed that endogenous Bcl-xL localizes to inner mitochondrial cristae in addition to the outer membrane, a localization pattern that appears consistent across multiple cell types.[11] The significance of this inner membrane localization became apparent when researchers discovered that Bcl-xL is required to stabilize the membrane potential across the inner mitochondrial membrane and prevent futile ion leakage through undefined inner membrane channels.[11] This mitochondrial membrane potential-stabilizing function represents a distinct mechanistic role for Bcl-xL that complements its canonical anti-apoptotic activities at the outer membrane.[11]

Endoplasmic Reticulum Localization and Calcium Regulation

In addition to its mitochondrial localization, Bcl-xL is found at endoplasmic reticulum (ER) membranes, where it exerts regulatory functions over calcium signaling and apoptotic sensitivity.[6][21][43][46] At the ER, Bcl-xL has been shown to functionally interact with inositol 1,4,5-trisphosphate receptors (IP₃Rs) and regulate IP₃-mediated calcium release from ER stores.[21][43][46] This interaction is particularly important because calcium flux from the ER to mitochondria plays a critical role in connecting ER stress to mitochondrial apoptosis.[21][46] By modulating ER calcium release, ER-localized Bcl-xL reduces intracellular calcium oscillations and limits the redistribution of calcium from the ER to mitochondria, thereby conferring resistance to apoptosis.[21][46]

Primary Anti-Apoptotic Function and Mechanism

Inhibition of BAX and BAK Effector Proteins

The canonical anti-apoptotic function of Bcl-xL centers on its ability to directly inhibit the pro-apoptotic effector proteins BAX and BAK, the critical mediators of mitochondrial outer membrane permeabilization (MOMP) that triggers the intrinsic apoptotic pathway.[1][4][7][14] BAX and BAK are multidomain pro-apoptotic proteins that, when activated, undergo conformational changes and oligomerize to form or enlarge pores in the outer mitochondrial membrane, permitting the release of intermembrane space proteins, including cytochrome c.[4][7][14][22] Bcl-xL prevents this catastrophic membrane disruption by binding directly to BAX and BAK through interactions mediated primarily by the BH1, BH2, and BH3 domains of Bcl-xL and corresponding domains in the pro-apoptotic effectors.[4][7][9][19]

The interaction between Bcl-xL and BAX or BAK involves insertion of the BH3 domain helix of the pro-apoptotic protein into the hydrophobic groove formed by the BH1-BH3 domains of Bcl-xL.[5][9][50][53] This binding interface has been extensively characterized through crystallographic and biochemical studies, revealing that the BH3 α-helix adopts an amphipathic structure with hydrophobic residues inserting into the Bcl-xL groove and polar residues making specific contacts with Bcl-xL residues positioned at the groove's surface.[5][50][53] Importantly, the binding of different BH3-containing proteins to Bcl-xL can induce differential conformational changes, with some proteins causing relatively subtle groove modifications while others, notably PUMA, induce more dramatic structural perturbations including partial unfolding of Bcl-xL itself.[5][59]

Regulation by BH3-Only Proteins and the Displacement Model

The pro-apoptotic BH3-only proteins represent the upstream triggers of BAX and BAK activation, and their regulation of Bcl-xL function is central to apoptotic control.[7][9][14][29] These proteins, which include BIM, BID, BAD, PUMA, and NOXA, contain a single BH3 domain that mediates interactions with anti-apoptotic Bcl-2 family members.[7][9][14] According to the anti-apoptotic protein neutralization or displacement model, healthy cells maintain BAX and BAK in an inactive state through constitutive binding to anti-apoptotic proteins like Bcl-xL and Mcl-1.[14] When apoptotic stimuli activate BH3-only proteins, these proteins competitively displace BAX and BAK from their anti-apoptotic binding partners through higher-affinity or more specific BH3-Bcl-xL interactions, permitting BAX and BAK liberation and activation.[14]

Certain BH3-only proteins, termed "sensitizer" or "de-repressor" proteins such as BAD, bind anti-apoptotic proteins but do not directly activate BAX or BAK, instead functioning to sequester anti-apoptotic proteins away from BAX and BAK.[9][14][29] Other BH3-only proteins, designated "direct activators" including BID and BIM, engage BAX and BAK directly in addition to or instead of binding anti-apoptotic proteins, actively promoting conformational changes that initiate MOMP.[9][14] This functional specialization creates a complex regulatory network where the specific combination of activated BH3-only proteins determines the precise apoptotic response.[9][14] Notably, Bcl-xL preferentially binds certain BH3-only proteins over others, with studies demonstrating that Bcl-xL shows strong binding preferences for BIM, HRK, and BIK peptides while showing weaker interaction with certain other BH3-only proteins.[9]

Phosphorylation and Post-Translational Modifications

The anti-apoptotic function of Bcl-xL is subject to dynamic regulation through post-translational modifications, particularly phosphorylation, which can modulate or even reverse its function.[20][23] Multiple kinases phosphorylate Bcl-xL at different residues, with each modification potentially altering protein conformation, protein-protein interactions, or cellular localization.[20][23] The cyclin-dependent kinase CDK2 phosphorylates Bcl-xL at serines 72, 73, and 74 in response to cisplatin-induced DNA damage, and this phosphorylation causes conformational changes that convert Bcl-xL from an anti-apoptotic protein capable of inhibiting BAX into a protein with pro-apoptotic properties that can activate BAX-dependent apoptosis even in the absence of additional stress.[20]

Polo-like kinase 1 (PLK1) phosphorylates Bcl-xL at serine 62 in response to DNA-damaging agents, stabilizing a cell cycle arrest at the G₂ checkpoint and promoting apoptosis.[23] The mitotic kinase PLK3 phosphorylates Bcl-xL at serine 49 in a cell cycle-dependent manner, with phosphorylation beginning at S phase and falling abruptly at mitosis onset.[17] These phosphorylation-mediated changes to Bcl-xL conformation and function appear to involve its unstructured loop region, highlighting the importance of conformational flexibility in this region to the ultimate function of the pro-survival protein.[20] The conformational and functional changes imparted by phosphorylation of the unstructured loop emphasize how dynamic post-translational modification of Bcl-xL allows cells to rapidly reprogram their apoptotic sensitivity in response to diverse cellular stresses.

Interactions with Mitochondrial Protein Complexes

Association with VDAC and Mitochondrial Function

Beyond its role in inhibiting BAX and BAK, Bcl-xL engages in critical interactions with the voltage-dependent anion channel (VDAC), a major outer membrane protein that forms an aqueous pore permitting the passage of ions and molecules up to approximately 5,000 Daltons.[4][15][16][22] The interaction between Bcl-xL and VDAC is functionally important in multiple contexts: Bcl-xL binding to VDAC1 and VDAC3 (but not VDAC2) promotes mitochondrial matrix Ca²⁺ accumulation by increasing Ca²⁺ transfer across the outer mitochondrial membrane.[15] This calcium-permitting function appears to distinguish the Bcl-xL/VDAC interaction from the well-characterized anti-apoptotic function, as the two activities appear to involve different molecular mechanisms and protein domains.[15]

Electrophysiological studies have demonstrated both increases and decreases in VDAC1 conductance upon Bcl-xL binding depending on experimental conditions, indicating that Bcl-xL can regulate VDAC function through multiple mechanisms.[15] The functional consequence of this VDAC interaction is biologically important: by promoting calcium transfer across the outer membrane, Bcl-xL enables optimal calcium signaling and mitochondrial calcium-dependent ATP synthesis, contributing to enhanced energy metabolism and cellular survival during periods of increased metabolic demand.[15] Conversely, disruption of the Bcl-xL/VDAC interaction, demonstrated through peptide-mediated competition, reduces mitochondrial calcium uptake and compromises cellular bioenergetics.[15]

Regulation of ATP Synthase Function and Metabolic Efficiency

Perhaps the most striking recent discovery regarding Bcl-xL function is its direct role in regulating the efficiency of the F₁F₀ ATP synthase complex and overall mitochondrial bioenergetics.[11][37][40] Pioneering investigations by the Jonas laboratory and collaborators revealed that endogenous Bcl-xL localizes to the inner mitochondrial membrane, where it directly binds to the β-subunit of the F₁F₀ ATP synthase.[11][36][37][40] This interaction has profound bioenergetic consequences: Bcl-xL decreases ion leak conductance within the F₁F₀ ATPase complex, thereby increasing the net transport of protons by F₁F₀ during ATP synthesis activity.[37][40] The mechanistic basis for this enhanced efficiency appears to involve closure of a leak channel within the ATP synthase complex, preventing futile proton dissipation that would otherwise dissipate the proton gradient without contributing to ATP synthesis.[37][40]

Biochemical assays and patch-clamp electrophysiology studies demonstrate that inhibition or depletion of Bcl-xL increases membrane leak conductance in ATP synthase-containing submitochondrial vesicles, directly confirming that endogenous Bcl-xL normally suppresses this conductance.[37][40] Exogenously applied recombinant Bcl-xL protein increases the rate of ATP hydrolysis in purified ATP synthase complexes, while small-molecule inhibitors of Bcl-xL (such as ABT-737) decrease enzymatic activity.[37][40] The functional consequence of this metabolic role for Bcl-xL is substantial: Bcl-xL-expressing hippocampal neurons display enhanced energy metabolism and superior synaptic transmission capability compared to Bcl-xL-deficient neurons, indicating that this metabolic function contributes meaningfully to neuronal physiology.[37][40]

This ATP synthase-regulatory function of Bcl-xL represents a fundamentally important discovery, establishing that anti-apoptotic Bcl-2 family proteins contribute to cell survival not merely through passive inhibition of death pathways but through active enhancement of cellular bioenergetics.[37][40] The interaction with ATP synthase provides a mechanistic explanation for why Bcl-xL-overexpressing cells often display enhanced proliferative and metabolic capacity independent of their apoptosis-resistance properties, and why this protein is particularly important in high-energy-demand cell types such as neurons.[37][40]

Regulation of Calcium Signaling and the Unfolded Protein Response

Bcl-xL at the Endoplasmic Reticulum

The endoplasmic reticulum (ER) functions as the major intracellular calcium storage compartment, and disturbances in ER calcium homeostasis can trigger both adaptive and maladaptive cellular responses.[21][46] Bcl-xL localizes to ER membranes in addition to mitochondria, and at this compartment, it exerts regulatory functions over calcium signaling and the unfolded protein response (UPR).[21][46] ER-localized Bcl-xL and Bcl-2 have been shown to reduce resting ER calcium content through enhanced leakage of calcium into the cytosol, an effect that appears mediated through altered interactions with IP₃Rs and calcium pump proteins.[21][46] This ER calcium-depleting function of Bcl-xL creates a protective phenotype by limiting the peak amplitude of calcium waves released from the ER in response to IP₃R activation.[21][46]

The interaction between Bcl-xL and the IP₃R is functionally significant: structural and biochemical studies demonstrate that Bcl-2 and its homologs form complexes with IP₃Rs in the ER membrane, and this interaction can modulate IP₃R-mediated calcium permeability.[46][43] By reducing the open probability of IP₃Rs when calcium is present, Bcl-xL limits calcium efflux from ER stores, thereby reducing the amplitude and duration of intracellular calcium transients.[43][46] This calcium-limiting function of Bcl-xL complements its role at mitochondria and contributes to overall apoptosis resistance by reducing the delivery of calcium to mitochondria, where excessive calcium uptake can trigger MOMP through either BAX/BAK activation or mitochondrial permeability transition pore opening.[21][46]

Interaction with Beclin 1 and Autophagy Regulation

Beyond its calcium-regulatory functions, Bcl-xL engages with the autophagy machinery through direct interactions with Beclin 1 (BECN1), a critical protein that initiates autophagosome formation by recruiting the class III phosphatidylinositol 3-kinase (PIK3C3/Vps34) complex to the ER.[31][39][42] Bcl-xL and other anti-apoptotic Bcl-2 family members bind to the BH3 domain of Beclin 1 through their hydrophobic groove, thereby sequestering Beclin 1 and preventing it from engaging Vps34, which is necessary for autophagosome initiation.[31][39][42] This Bcl-xL-mediated inhibition of autophagy can be relieved by BH3-only proteins that displace Beclin 1 from Bcl-xL, providing a mechanism through which apoptotic and autophagic pathways are coordinately regulated.[31][39][42]

Recent evidence indicates that phosphorylation of Beclin 1 at threonine 108 by the serine-threonine kinase STK4/MST1 increases the affinity of BECN1 for anti-apoptotic proteins including Bcl-xL and Bcl-2, thereby enhancing inhibition of autophagy.[31][42] The phosphorylation appears to create an electrostatic interaction with a conserved histidine residue on Bcl-xL, increasing binding stability.[31][42] This multilayered regulation of the Bcl-xL/Beclin 1 interaction allows cells to fine-tune the balance between apoptosis and autophagy based on phosphorylation status and cellular metabolic state, highlighting how the Bcl-xL protein integrates multiple cellular survival and death pathways.[31][39][42]

Role in Development and Tissue Homeostasis

Essential Function in Pancreatic Cell Differentiation

Recent investigations have demonstrated that Bcl-xL plays an essential role in supporting the survival and function of pancreatic cells during differentiation from human pluripotent stem cells.[1] Pancreatic specification involves dynamic regulation of cellular proliferation and apoptosis during transitions between developmental stages, and emerging evidence indicates that anti-apoptotic proteins including Bcl-xL are critical for establishing cellular identity in this context.[1] Expression profiling during pancreatic differentiation revealed upregulation of Bcl-xL, downregulation of pro-apoptotic BAK, and corresponding downregulation of cleaved caspase-3, indicating that apoptosis inhibition is an important feature of normal pancreatic development.[1]

Experimental inhibition of Bcl-xL using the selective inhibitor WEHI-539 led to reciprocal increases in apoptosis and resulted in marked decreases in pancreatic marker gene expression despite compensatory increases in the anti-apoptotic protein Bcl-2.[1] RNA sequencing revealed that Bcl-xL inhibition resulted in widespread downregulation of metabolic genes, and bioenergetics assays demonstrated that Bcl-xL inhibition caused broad downregulation of both glycolysis and oxidative phosphorylation.[1] Early perturbation of Bcl-xL during pancreatic specification had detrimental effects on the formation of INS⁺ pancreatic beta-like cells, indicating that this protein is essential for generating functional pancreatic tissue.[1] These observations demonstrate that modulation of Bcl-xL expression level can potentially increase the survival and robustness of pancreatic progenitors that ultimately define pancreatic beta cell mass and function, suggesting therapeutic applications for diabetes treatment.[1]

Function in Retinal Development and Neuronal Survival

Bcl-xL expression is particularly important in the nervous system, where it supports neuronal survival during development and following injury.[28][57] In the developing retina, Bcl-xL is expressed throughout the neuroblastic retina and in retinal ganglion cells (RGCs), the earliest-born retinal neurons.[28][57] Conditional deletion of Bcl-x from developing retinas resulted in widespread ectopic cell death in RGCs, leading to premature loss of large numbers of RGCs between embryonic days E12.5 and E18.5.[28][57] During this critical developmental period, ectopic caspase-3 activation and retinal thinning were evident, indicating that cell death is coincident with loss of RGCs when Bcl-xL is absent.[28][57]

These studies demonstrated that immature RGCs require Bcl-xL for survival, as proper retinal development requires a significant amount of programmed cell death that is dependent on pro-apoptotic Bcl-2 family members, and Bcl-xL functions to counteract this pro-apoptotic signaling during early neuronal differentiation.[28][57] Notably, while Bcl-xL is required for RGC survival during development, the protein is not essential for maintaining RGC viability in adult retinas under basal conditions.[28][57] However, the loss of Bcl-xL in adult RGCs significantly increased the rate of neuronal death after axonal injury, indicating an important role for this protein in supporting neuronal survival during stress.[28][57] The relative expression level of Bcl-xL is thus critical to determining how much insult a neuron can withstand before undergoing apoptosis, and fluctuations in Bcl-xL expression appear sufficient to determine vulnerability to injury-induced death.[28][57]

Dysregulation in Cancer and Therapeutic Targeting

Overexpression in Hematologic Malignancies

Dysregulation of BCL2L1 expression is a hallmark feature of hematologic malignancies and is strongly associated with apoptosis resistance and chemotherapy resistance.[25][27][51][55] In acute myeloid leukemia (AML), overexpression of BCL2L1 is manifested in patients resistant to chemotherapy, with Bcl-xL demonstrating the highest expression levels among all Bcl-2 family members in chemotherapy-resistant AML populations.[25][55] The association between Bcl-xL expression and therapy resistance is clinically significant, as high Bcl-xL levels predict poor response to standard induction chemotherapy in newly diagnosed AML patients.[25][51][55] In lymphoid malignancies including chronic lymphocytic leukemia (CLL) and non-Hodgkin's lymphoma (NHL), Bcl-xL is frequently overexpressed and contributes to apoptosis evasion and disease progression.[51][54]

The dysregulation of BCL2L1 expression appears to reflect intrinsic importance of this protein to the cell-of-origin of certain malignancies rather than recurrent genetic mutations in the gene itself.[25][55] Genomic and exome sequencing analyses indicate that BCL2 family genes, including BCL2L1, are rarely mutated in AML, but their expression is frequently dysregulated and correlates with mutational status of other genes including those recurrently mutated in AML and splicing-related genes.[25][55] This expression dysregulation likely reflects selective pressure for survival signaling in the context of oncogenic mutations that would otherwise trigger apoptosis, making anti-apoptotic proteins like Bcl-xL essential for malignant transformation and disease propagation.[25][27][51][55]

BH3 Mimetic Therapy Targeting Bcl-xL

The anti-apoptotic function of Bcl-xL makes it an attractive therapeutic target, and the first-in-class small-molecule BH3 mimetic ABT-737 and its orally available derivative ABT-263 (navitoclax) were developed to inhibit Bcl-xL and related anti-apoptotic proteins.[13][27][51][54] These molecules bind to the hydrophobic groove of Bcl-xL and related pro-survival proteins with high affinity, displacing bound BH3-only proteins and BAX/BAK, thereby enabling apoptosis induction.[27][51][54] Venetoclax, a highly selective BCL-2 inhibitor with some Bcl-xL activity, has demonstrated striking efficacy in CLL and has been approved for clinical use, achieving response rates of 71-79% even among patients with poor prognostic features including fludarabine resistance and 17p deletions.[51]

However, development of selective Bcl-xL inhibitors faces a significant clinical challenge related to platelet toxicity, as Bcl-xL is essential for platelet survival and non-selective inhibition causes thrombocytopenia limiting drug tolerability.[13][51] To address this issue, researchers have developed Bcl-xL-selective PROTACs (proteolysis-targeting chimeras) including DT2216 and PZ15227, which target Bcl-xL to the Von Hippel-Lindau or cereblon E3 ligases, respectively, for proteasomal degradation.[13] These targeted degradation strategies achieve improved antitumor potency with reduced platelet toxicity compared to conventional BH3 mimetics like ABT-263.[13] Additionally, selective small-molecule Bcl-xL inhibitors such as A1155463 and A1331852 are in preclinical development and show promise for killing ABT-199-resistant AML cells that express high Bcl-xL levels.[13]

Resistance Mechanisms and Combination Strategies

Despite impressive initial responses to BH3 mimetics targeting Bcl-xL and related anti-apoptotic proteins, secondary resistance emerges frequently with long-term exposure, often mediated by genetic or adaptive changes in the apoptotic pathway.[54] Increased expression of Mcl-1, an anti-apoptotic protein with distinct BH3 binding preferences from Bcl-xL and Bcl-2, is a common mechanism of resistance to these targeted inhibitors.[27][51][54] Combined targeting of Bcl-xL/Bcl-2 and Mcl-1 using dual inhibitors or combination therapies shows promise in preclinical models and early clinical investigations.[27][30][41]

Recent findings demonstrate that combining p53 activation with Bcl-xL/Bcl-2 inhibition produces synergistic apoptosis induction through a mechanism involving enhanced expression of the Mcl-1-binding pro-apoptotic protein NOXA.[41] Treatment with the MDM2 inhibitor idasanutlin combined with the Bcl-xL/Bcl-2 inhibitor navitoclax shows particularly potent activity in acute lymphoblastic leukemia (ALL), with the combination demonstrating superior antileukemic activity compared to either agent alone by preferentially engaging cell death over cell cycle arrest.[41] This mechanistic insight provides a rationale for rational combination strategies that exploit complementary apoptotic regulatory mechanisms to overcome therapeutic resistance.[41]

Integration into Multiple Cellular Pathways

Regulation by p53 and Response to DNA Damage

The tumor suppressor protein p53 functions as a master regulator of apoptotic responses and coordinates transcriptional programs controlling both pro-apoptotic and anti-apoptotic genes.[38][49][52] P53 represses transcription of anti-apoptotic genes including BCL-2 and BCL2L1, providing a mechanism through which p53 activation promotes apoptosis by reducing the expression of anti-apoptotic proteins.[38][49][52] Additionally, p53 can interact directly with Bcl-xL at the mitochondrial membrane in a transcription-independent manner, with Bcl-xL binding to the DNA-binding domain of p53 and blocking its pro-apoptotic activity.[52] This direct p53-Bcl-xL interaction can be disrupted by pro-apoptotic proteins including PUMA, which induces partial unfolding of Bcl-xL and disrupts its interface with p53, thereby releasing p53 to engage BAX and trigger MOMP.[52][59]

Phosphorylation of Bcl-xL in response to DNA damage by CDK2 and other kinases modulates the protein's anti-apoptotic function and can even convert it into a pro-apoptotic protein capable of triggering BAX activation independent of pro-apoptotic BH3-only proteins.[20] This phosphorylation-mediated functional switch provides a mechanism through which cell cycle checkpoint kinases integrate apoptotic control with cell cycle surveillance, ensuring that cells with irreparable DNA damage undergo apoptosis rather than continuing through the cell cycle.[20]

Interaction with Parkin and Mitochondrial Quality Control

The E3 ubiquitin ligase Parkin, which is mutated in early-onset Parkinson's disease, interacts directly with Bcl-2 and indirectly regulates Bcl-xL, modulating both apoptosis and autophagy.[39] Parkin ubiquitinates Bcl-2 and related anti-apoptotic proteins, affecting their stability and interactions with Beclin 1.[39] The interaction between Parkin and Bcl-2 results in increased stability of Bcl-2, which strengthens binding between Beclin 1 and Bcl-2 in an Parkin-dependent manner requiring E3 ligase activity.[39] This Parkin-mediated regulation links mitochondrial quality control mechanisms to apoptotic and autophagic pathways through direct interactions with Bcl-xL and related proteins.[39]

Proteasomal Degradation and Protein Stability Regulation

Post-Translational Modification and Turnover

The cellular levels of Bcl-xL are regulated not only through transcriptional and translational control but also through post-translational modifications that target the protein for proteasomal degradation.[44][47] Multiple ubiquitin ligases have been identified as mediating Bcl-xL ubiquitination and subsequent proteasomal degradation, providing mechanisms through which cellular stress signals can rapidly reduce Bcl-xL levels and prime cells for apoptosis.[44][47] The USP9x deubiquitinase counteracts ubiquitin ligase-mediated Bcl-xL degradation, prolonging its half-life and stabilizing anti-apoptotic signaling.[44]

GSK3β-dependent phosphorylation of pro-apoptotic Bcl-2 family members including Mcl-1 targets these proteins for degradation, with inhibition of the upstream kinase AKT resulting in increased GSK3β activity and enhanced degradation.[44] The interplay between kinase and phosphatase signaling determines the phosphorylation status and thus the stability and function of both anti-apoptotic and pro-apoptotic Bcl-2 family members, allowing diverse signaling pathways to converge on apoptotic control through Bcl-xL regulation.[44]

Tissue Distribution and Expression Patterns

Prominent Expression in High-Energy Demand Tissues

BCL2L1 transcript expression shows prominent enrichment in tissues with high energy demands and active proliferation, particularly the nervous system, immune system, and developing tissues.[45][48] Within the nervous system, Bcl-xL is abundantly expressed in neurons throughout the brain including the hippocampus, cerebral cortex, cerebellum, and spinal cord, reflecting the critical importance of this protein for neuronal survival and metabolic efficiency.[45] In the immune system, Bcl-xL is highly expressed in bone marrow cells, lymph nodes, thymus, and spleen, where it supports the survival of developing and mature lymphocytes.[45] In peripheral tissues, Bcl-xL is expressed in the heart, where it contributes to cardiomyocyte survival and metabolic efficiency.[45]

The distribution pattern of Bcl-xL expression reflects the particular vulnerability of these cell types to apoptotic signals and their dependence on sustained anti-apoptotic signaling for survival and function.[45] The prominence of Bcl-xL in developing tissues suggests important roles in developmental programming and tissue differentiation, while its expression in terminally differentiated tissues including neurons and cardiac myocytes indicates continued importance for adult tissue homeostasis and stress responses.[45]

Conclusion and Future Perspectives

BCL2L1 encodes one of the most multifunctional proteins in mammalian cells, operating at the critical intersection of apoptosis, metabolism, calcium signaling, and autophagy regulation to determine cell fate in health and disease. The protein exists in two functionally antagonistic isoforms generated through alternative splicing, providing an elegant regulatory mechanism for tuning cellular apoptotic sensitivity. Beyond its canonical role as an inhibitor of BAX and BAK-mediated apoptosis, Bcl-xL has emerged as a critical regulator of mitochondrial bioenergetics, enhancing ATP synthesis efficiency through direct interaction with ATP synthase and contributing to enhanced neuronal and metabolic function. Its localization to multiple intracellular compartments including outer and inner mitochondrial membranes, endoplasmic reticulum, and possibly other organelles reflects its multifaceted cellular roles.

The dysregulation of BCL2L1 expression is a hallmark of hematologic malignancies and other cancers, making this protein an important therapeutic target. The development of BH3 mimetics and selective Bcl-xL degraders has opened new avenues for cancer treatment, though emerging resistance mechanisms require rational combination strategies exploiting complementary apoptotic regulatory mechanisms. Understanding the precise molecular mechanisms through which Bcl-xL regulates ATP synthase function, calcium homeostasis, and autophagy will be critical for developing next-generation therapeutics that can selectively target specific Bcl-xL functions while minimizing off-target toxicity. Future investigations employing advanced structural biology techniques, cell biology approaches, and animal disease models will continue to reveal the full scope of this remarkable protein's biological importance and therapeutic potential.

Citations

https://pubmed.ncbi.nlm.nih.gov/32424151/
https://www.rcsb.org/structure/1r2d
https://pubmed.ncbi.nlm.nih.gov/10889511/
https://en.wikipedia.org/wiki/Bcl-2-like_protein_1
https://pmc.ncbi.nlm.nih.gov/articles/PMC6540150/
https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2018.00013/full
https://pmc.ncbi.nlm.nih.gov/articles/PMC3576097/
https://rupress.org/jcb/article/160/1/53/33123/Characterization-of-the-signal-that-directs-Bcl-xL
https://pmc.ncbi.nlm.nih.gov/articles/PMC2928556/
https://febs.onlinelibrary.wiley.com/doi/10.1111/febs.14186
https://pmc.ncbi.nlm.nih.gov/articles/PMC3198165/
https://genesdev.cshlp.org/content/19/11/1294
https://pmc.ncbi.nlm.nih.gov/articles/PMC8323006/
https://pmc.ncbi.nlm.nih.gov/articles/PMC3242477/
https://pmc.ncbi.nlm.nih.gov/articles/PMC3707689/
https://pmc.ncbi.nlm.nih.gov/articles/PMC3603586/
https://www.pnas.org/doi/10.1073/pnas.0600103103
https://www.cellsignal.com/learn-and-support/protein-domains-and-interactions/bh14-protein-domains
https://pmc.ncbi.nlm.nih.gov/articles/PMC4877050/
https://journals.physiology.org/doi/full/10.1152/ajpcell.00612.2008
https://en.wikipedia.org/wiki/Bcl-2_family
https://aacrjournals.org/mct/article/6/11_Supplement/A109/240581/Phosphorylation-of-Bcl-xL-by-polo-like-kinase-1
https://pubmed.ncbi.nlm.nih.gov/15719013/
https://pmc.ncbi.nlm.nih.gov/articles/PMC8267690/
https://www.spandidos-publications.com/10.3892/or.2015.4465
https://pmc.ncbi.nlm.nih.gov/articles/PMC3955095/
https://pmc.ncbi.nlm.nih.gov/articles/PMC3436941/
https://pmc.ncbi.nlm.nih.gov/articles/PMC6743414/
https://aacrjournals.org/mct/article/16/10/2178/272131/A-Novel-Combination-Treatment-Targeting-BCL-XL-and
https://pmc.ncbi.nlm.nih.gov/articles/PMC6526822/
https://pubmed.ncbi.nlm.nih.gov/11044408/
https://pubmed.ncbi.nlm.nih.gov/8244956/
https://www.tandfonline.com/doi/abs/10.1080/15548627.2018.1564557
https://ashpublications.org/blood/article/141/13/1610/493714/Erythroid-megakaryocytic-differentiation-confers
https://www.uniprot.org/uniprotkb/Q07817/entry
https://pmc.ncbi.nlm.nih.gov/articles/PMC3186867/
https://academic.oup.com/nar/article/32/15/4480/2375708
https://pmc.ncbi.nlm.nih.gov/articles/PMC3901098/
https://pubmed.ncbi.nlm.nih.gov/21926988/
https://pmc.ncbi.nlm.nih.gov/articles/PMC11147763/
https://pubmed.ncbi.nlm.nih.gov/16874461/
https://pmc.ncbi.nlm.nih.gov/articles/PMC10772529/
https://www.proteinatlas.org/ENSG00000171552-BCL2L1
https://www.science.org/doi/10.1126/stke.2432004tw268
https://febs.onlinelibrary.wiley.com/doi/10.1111/febs.14516
https://www.ncbi.nlm.nih.gov/gene/598
https://pmc.ncbi.nlm.nih.gov/articles/PMC516049/
https://www.frontiersin.org/journals/hematology/articles/10.3389/frhem.2023.1307661/full
https://academic.oup.com/jmcb/article/14/10/mjac074/6960679
https://pmc.ncbi.nlm.nih.gov/articles/PMC3263372/
https://pubmed.ncbi.nlm.nih.gov/34320168/
https://pmc.ncbi.nlm.nih.gov/articles/PMC2865346/
https://pmc.ncbi.nlm.nih.gov/articles/PMC3683295/
the anti-apoptotic protein neutralization or displacement model

Notes

(BCL2L1-notes.md)

BCL2L1 (Bcl-x) Notes - ISOFORMS Project

Key Isoform Biology

BCL2L1 is a paradigm case of antagonistic isoform functions in alternative splicing.

Three Known Isoforms (UniProt)

Isoform	UniProt ID	Function	Mechanism
Bcl-X(L)	Q07817-1	Anti-apoptotic	Inhibits caspases, blocks VDAC, prevents CYC1 release
Bcl-X(S)	Q07817-2	Pro-apoptotic	Promotes apoptosis (lacks BH1/BH2 domains)
Bcl-X(beta)	Q07817-3	Unknown	Third isoform, less studied

Tissue Distribution

Bcl-X(S): High in cells with high turnover (developing lymphocytes)
Bcl-X(L): High in long-lived postmitotic cells (adult brain)

Domain Structure Differences

Bcl-X(L): Contains BH1, BH2, BH3, BH4 domains
Bcl-X(S): Lacks BH1 and BH2 domains (alternative 5' splice site in exon 2)
The BH4 motif is required for anti-apoptotic activity
BH1/BH2 are required for heterodimerization with other Bcl-2 family members

Problem: Conflated GO Annotations

The current GOA file has 157 annotations but NO isoform-specific annotations (no Q07817-1 or Q07817-2).

Conflicting Annotations Identified

Pro-apoptotic annotations (likely Bcl-X(S)):
- GO:0043065 "positive regulation of apoptotic process" - IBA

Anti-apoptotic annotations (likely Bcl-X(L)):
- GO:0043066 "negative regulation of apoptotic process" - IDA (multiple PMIDs)
- GO:1902236 "negative regulation of ER stress-induced intrinsic apoptotic signaling pathway" - IDA
- GO:1902042 "negative regulation of extrinsic apoptotic signaling pathway via death domain receptors" - IDA
- GO:1902230 "negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage" - IDA
- GO:2001240 "negative regulation of extrinsic apoptotic signaling pathway in absence of ligand" - TAS
- GO:1900118 "negative regulation of execution phase of apoptosis" - IDA
- GO:2001243 "negative regulation of intrinsic apoptotic signaling pathway" - IDA

The Core Issue

When you see both "positive regulation of apoptosis" AND "negative regulation of apoptosis" for the same gene, this is usually a sign of:
1. Isoform conflation (this case)
2. Context-dependent functions
3. Cleaved vs full-length protein (BCL2L1 also has this - caspase cleavage removes BH4, converting anti-apoptotic to pro-apoptotic)

Key References

Original Discovery

PMID:8358789 - Boise et al. 1993 "bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death"
Describes both Bcl-X(L) and Bcl-X(S) isoforms
Shows Bcl-X(L) inhibits apoptosis; Bcl-X(S) promotes it

Bcl-X(beta) Isoform

PMID:9675101 - Ban et al. 1998 "Identification of a human cDNA encoding a novel Bcl-x isoform"

Review Strategy

Annotations with IDA evidence: Check which isoform was actually used in experiments
IBA annotation to GO:0043065: This may incorrectly infer pro-apoptotic function from paralogs
IEA annotations: These are automated and likely conflate isoforms
Consider proposing isoform-specific annotations with reference to Q07817-1 and Q07817-2

Cancer Relevance

Bcl-X(L) overexpression confers drug resistance in cancer
Bcl-X(L) is a therapeutic target (BH3 mimetics like navitoclax)
Splicing factor mutations can shift the Bcl-xL/Bcl-xS ratio

Questions for Review

Are there any papers that specifically tested Bcl-X(S)?
Should the IBA annotation to GO:0043065 be REMOVED since it may not apply to the canonical isoform?
Which isoform was used in each IDA experiment?

📄 View Raw YAML

id: Q07817
gene_symbol: BCL2L1
product_type: PROTEIN
status: COMPLETE
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: 'BCL2L1 encodes Bcl-2-like protein 1 (also called Bcl-x), a member of
  the Bcl-2 family that regulates apoptosis. CRITICAL ISOFORM BIOLOGY: Alternative
  splicing produces two functionally ANTAGONISTIC isoforms: (1) Bcl-xL (Q07817-1,
  233 AA) is anti-apoptotic and inhibits BAX/BAK-mediated mitochondrial outer membrane
  permeabilization; (2) Bcl-xS (Q07817-2, 166 AA) is pro-apoptotic, lacks BH1/BH2
  domains, and can heterodimerize with Bcl-xL to inhibit its function. Most GO annotations
  refer to Bcl-xL, the dominant isoform. The annotation GO:0043065 "positive regulation
  of apoptotic process" likely reflects Bcl-xS function or IBA inference error. Beyond
  apoptosis, Bcl-xL regulates ATP synthase efficiency, calcium signaling, and autophagy.'
existing_annotations:
  - term:
      id: GO:0043065
      label: positive regulation of apoptotic process
    evidence_type: IBA
    original_reference_id: GO_REF:0000033
    review:
      summary: ISOFORM-CONFLATED ANNOTATION. This annotation is misleading when 
        applied to the gene as a whole. The canonical isoform Bcl-xL (Q07817-1) 
        is ANTI-apoptotic, not pro-apoptotic. Only the short isoform Bcl-xS 
        (Q07817-2) promotes apoptosis. The IBA evidence (phylogenetic inference)
        does not distinguish between isoforms and may reflect Bcl-xS function or
        misannotation of paralogs in the Bcl-2 family. The original paper 
        PMID:8358789 clearly shows "bcl-xL inhibits cell death" while "bcl-xS 
        encodes a protein that inhibits the ability of bcl-2 to enhance 
        survival."
      action: MARK_AS_OVER_ANNOTATED
      reason: This annotation conflates the pro-apoptotic function of Bcl-xS 
        with the gene as a whole. The dominant Bcl-xL isoform is anti-apoptotic.
        If retained, this should be isoform-specific to Q07817-2 (Bcl-xS). The 
        IBA evidence does not provide isoform resolution.
      supported_by:
        - reference_id: PMID:8358789
          supporting_text: bcl-xS, encodes a protein that inhibits the ability 
            of bcl-2 to enhance the survival of growth factor-deprived cells
        - reference_id: file:human/BCL2L1/BCL2L1-deep-research-perplexity.md
          supporting_text: 'provider: perplexity'
  - term:
      id: GO:0097192
      label: extrinsic apoptotic signaling pathway in absence of ligand
    evidence_type: IBA
    original_reference_id: GO_REF:0000033
    review:
      summary: Bcl-xL participates in the extrinsic apoptotic signaling pathway,
        particularly in absence of ligand (growth factor withdrawal). 
        PMID:8358789 demonstrated that Bcl-xL inhibits cell death upon growth 
        factor withdrawal. PMID:7650367 showed that "Stable transfection of 
        either bcl-2 or bcl-x expression plasmids promotes the survival of 
        CTLL-2 cells in the setting of IL-2 withdrawal." This IBA annotation 
        appropriately captures Bcl-xL's role in this pathway, though the term 
        could be more specific about the direction of regulation.
      action: ACCEPT
      reason: The IBA annotation correctly places BCL2L1 in the extrinsic 
        apoptotic pathway context. The foundational paper PMID:8358789 shows 
        Bcl-xL inhibits cell death upon growth factor withdrawal. However, this 
        is a process annotation rather than a regulatory term, which is 
        acceptable as Bcl-xL is indeed involved in this pathway as an inhibitor.
        The function is core to Bcl-xL biology.
      supported_by:
        - reference_id: PMID:8358789
          supporting_text: bcl-xL inhibits cell death upon growth factor 
            withdrawal at least as well as bcl-2
        - reference_id: PMID:7650367
          supporting_text: Stable transfection of either bcl-2 or bcl-x 
            expression plasmids promotes the survival of CTLL-2 cells in the 
            setting of IL-2 withdrawal
  - term:
      id: GO:0005741
      label: mitochondrial outer membrane
    evidence_type: IBA
    original_reference_id: GO_REF:0000033
    review:
      summary: Core localization for Bcl-xL. UniProt states "Mitochondrion outer
        membrane" as a primary location. The deep research confirms "The 
        selective targeting of Bcl-xL to the mitochondrial outer membrane (MOM) 
        is mediated by the positively charged residues flanking its hydrophobic 
        transmembrane domain." The C-terminal transmembrane domain (residues 
        210-226) functions as a mitochondrial targeting signal. At the MOM, 
        Bcl-xL resides near VDACs and regulates MOMP.
      action: ACCEPT
      reason: Well-established core localization. The transmembrane domain 
        directs Bcl-xL specifically to the MOM where it performs its 
        anti-apoptotic function by inhibiting BAX/BAK. Multiple structural and 
        cell biology studies confirm this localization.
      supported_by:
        - reference_id: PMID:9843949
          supporting_text: Bax-induced mitochondrial changes were inhibited by 
            recombinant Bcl-xL and transgene-derived Bcl-2, antiapoptotic 
            members of the Bcl-2 family
  - term:
      id: GO:0008630
      label: intrinsic apoptotic signaling pathway in response to DNA damage
    evidence_type: IBA
    original_reference_id: GO_REF:0000033
    review:
      summary: Bcl-xL is involved in the intrinsic apoptotic pathway in response
        to DNA damage. PMID:16608847 demonstrates that "PUMA Dissociates Bax and
        Bcl-X(L) to induce apoptosis in colon cancer cells" in the context of 
        DNA damage (adriamycin treatment). The paper shows "PUMA-dependent 
        apoptosis induced by the DNA-damaging agent adriamycin" is regulated by 
        Bcl-xL. The annotation captures Bcl-xL's role as a negative regulator in
        this pathway.
      action: ACCEPT
      reason: Bcl-xL is a key negative regulator of the intrinsic apoptotic 
        pathway triggered by DNA damage. It binds and sequesters pro-apoptotic 
        BH3-only proteins like PUMA that are induced by p53 in response to DNA 
        damage. This is a core function of Bcl-xL.
      supported_by:
        - reference_id: PMID:16608847
          supporting_text: PUMA initiates apoptosis in part by dissociating Bax 
            and Bcl-X(L), thereby promoting Bax multimerization and 
            mitochondrial translocation
  - term:
      id: GO:0015267
      label: channel activity
    evidence_type: IBA
    original_reference_id: GO_REF:0000033
    review:
      summary: Bcl-xL regulates ion channel activity at mitochondrial membranes.
        UniProt notes Bcl-xL "blocking the voltage-dependent anion channel 
        (VDAC) by binding to it." The deep research states "Bcl-xL decreases ion
        leak conductance within the F1F0 ATPase complex" and "Bcl-xL binding to 
        VDAC1 and VDAC3 promotes mitochondrial matrix Ca2+ accumulation." 
        However, this is a regulatory activity on channels, not direct channel 
        activity by Bcl-xL itself.
      action: MODIFY
      reason: Bcl-xL regulates channel activity but is not itself a channel. It 
        interacts with VDAC and modulates ion leak through ATP synthase, but 
        these are regulatory functions. A more accurate term would be related to
        channel regulation rather than direct channel activity.
      proposed_replacement_terms:
        - id: GO:0099101
          label: regulation of ion channel activity
      supported_by:
        - reference_id: PMID:9843949
          supporting_text: Bax-induced mitochondrial changes were inhibited by 
            recombinant Bcl-xL... suggesting a possible regulatory effect of 
            F0F1-ATPase on Bax-induced mitochondrial changes
  - term:
      id: GO:0001836
      label: release of cytochrome c from mitochondria
    evidence_type: IBA
    original_reference_id: GO_REF:0000033
    review:
      summary: Bcl-xL NEGATIVELY regulates cytochrome c release. PMID:9843949 
        shows "Bax interacts with the permeability transition pore to induce 
        permeability transition and cytochrome c release" and "Bax-induced 
        mitochondrial changes were inhibited by recombinant Bcl-xL." UniProt 
        states Bcl-xL functions by "preventing the release of the caspase 
        activator, CYC1, from the mitochondrial membrane." This annotation is 
        problematic as written - Bcl-xL is involved in this process but as a 
        NEGATIVE regulator.
      action: MODIFY
      reason: The term "release of cytochrome c from mitochondria" implies the 
        protein promotes this release. Bcl-xL actually INHIBITS this release. 
        The correct annotation should be GO:0090201 "negative regulation of 
        release of cytochrome c from mitochondria" which is already annotated 
        elsewhere in the GOA.
      proposed_replacement_terms:
        - id: GO:0090201
          label: negative regulation of release of cytochrome c from 
            mitochondria
      supported_by:
        - reference_id: PMID:9843949
          supporting_text: Bax-induced mitochondrial changes were inhibited by 
            recombinant Bcl-xL and transgene-derived Bcl-2
  - term:
      id: GO:0055085
      label: transmembrane transport
    evidence_type: IEA
    original_reference_id: GO_REF:0000108
    review:
      summary: Automated annotation based on logical inference. Bcl-xL regulates
        transmembrane transport indirectly through its interactions with VDAC 
        and effects on mitochondrial membrane permeability. However, Bcl-xL is 
        not itself a transporter. This term is overly broad and does not 
        accurately capture the molecular function.
      action: MARK_AS_OVER_ANNOTATED
      reason: This IEA annotation is too general. Bcl-xL regulates membrane 
        permeability and ion transport indirectly through protein-protein 
        interactions (with VDAC, BAX, BAK), not by directly performing transport
        activity. The annotation lacks specificity about the actual mechanism.
  - term:
      id: GO:0005741
      label: mitochondrial outer membrane
    evidence_type: IEA
    original_reference_id: GO_REF:0000120
    review:
      summary: IEA annotation for mitochondrial outer membrane localization, 
        which is consistent with the IBA annotation already reviewed. This 
        automated annotation is correct and well-supported by experimental data.
        The MOM is the primary site of Bcl-xL function.
      action: ACCEPT
      reason: Duplicate of IBA annotation for the same cellular component. The 
        MOM localization is well-established and core to Bcl-xL function. 
        Multiple evidence types supporting the same annotation is acceptable.
  - term:
      id: GO:0005743
      label: mitochondrial inner membrane
    evidence_type: IEA
    original_reference_id: GO_REF:0000044
    review:
      summary: UniProt notes "Mitochondrion inner membrane" as a localization 
        for Bcl-xL. The deep research states "Bcl-xL protein also localizes to 
        the MIM in hippocampal neurons, where it directly binds to the 
        beta-subunit of the F1F0 ATP synthase." This inner membrane localization
        is associated with the non-apoptotic metabolic function of Bcl-xL.
      action: ACCEPT
      reason: Secondary localization supported by evidence. While the MOM is the
        primary location, Bcl-xL has been detected at the inner membrane where 
        it regulates ATP synthase efficiency. This is a legitimate secondary 
        localization associated with a non-canonical but well-documented 
        function.
  - term:
      id: GO:0005759
      label: mitochondrial matrix
    evidence_type: IEA
    original_reference_id: GO_REF:0000044
    review:
      summary: UniProt notes "Mitochondrion matrix" as a localization. The deep 
        research mentions matrix localization "in certain cell types and 
        contexts." This is a minor localization compared to the outer membrane.
      action: KEEP_AS_NON_CORE
      reason: The mitochondrial matrix localization is reported but represents a
        minor fraction of Bcl-xL. The primary functional localization is at the 
        outer membrane. Matrix localization may be context-dependent and is not 
        central to the core anti-apoptotic function.
  - term:
      id: GO:0005813
      label: centrosome
    evidence_type: IEA
    original_reference_id: GO_REF:0000044
    review:
      summary: UniProt states "Localizes to the centrosome when phosphorylated 
        at Ser-49." PMID:21840391 shows that "During DNA damage-induced G2 
        arrest, an important pool of phospho-Bcl-xL(Ser49) accumulates in 
        centrosomes which act as essential decision centers for progression from
        G2 to mitosis."
      action: KEEP_AS_NON_CORE
      reason: Centrosome localization is conditional (requires Ser49 
        phosphorylation) and related to cell cycle checkpoint function rather 
        than the core anti-apoptotic function. This is a legitimate but non-core
        localization.
      supported_by:
        - reference_id: PMID:21840391
          supporting_text: During DNA damage-induced G2 arrest, an important 
            pool of phospho-Bcl-xL(Ser49) accumulates in centrosomes which act 
            as essential decision centers for progression from G2 to mitosis
  - term:
      id: GO:0005829
      label: cytosol
    evidence_type: IEA
    original_reference_id: GO_REF:0000120
    review:
      summary: UniProt notes "Cytoplasm, cytosol" as a localization. The deep 
        research states "After neuronal stimulation, translocates from cytosol 
        to synaptic vesicle and mitochondrion membrane in a calmodulin-dependent
        manner." A cytosolic pool of Bcl-xL exists before membrane insertion.
      action: ACCEPT
      reason: Cytosolic localization is valid. Bcl-xL has a soluble cytosolic 
        form before insertion into membranes, and can translocate between 
        cytosol and membranes in response to stimuli.
  - term:
      id: GO:0006897
      label: endocytosis
    evidence_type: IEA
    original_reference_id: GO_REF:0000043
    review:
      summary: UniProt notes that Bcl-xL "regulates endocytic vesicle retrieval 
        in hippocampal neurons through association with DMN1L and stimulation of
        its GTPase activity in synaptic vesicles." This represents a 
        non-apoptotic neuronal function.
      action: KEEP_AS_NON_CORE
      reason: Endocytosis regulation is a specialized neuronal function of 
        Bcl-xL, separate from its core anti-apoptotic role. It involves 
        interaction with Drp1/DMN1L at synaptic vesicles. This is a legitimate 
        but tissue-specific non-core function.
  - term:
      id: GO:0006915
      label: apoptotic process
    evidence_type: IEA
    original_reference_id: GO_REF:0000120
    review:
      summary: Bcl-xL is indeed involved in apoptosis as a NEGATIVE regulator. 
        PMID:8358789 established that "bcl-xL inhibits cell death upon growth 
        factor withdrawal." The term is accurate but very broad - Bcl-xL 
        specifically negatively regulates apoptosis.
      action: ACCEPT
      reason: BCL2L1 is fundamentally involved in apoptotic process regulation. 
        While this term is broad, it is accurate. The gene is a central 
        regulator of apoptosis and the IEA annotation is appropriate as a 
        high-level annotation.
  - term:
      id: GO:0006950
      label: response to stress
    evidence_type: IEA
    original_reference_id: GO_REF:0000117
    review:
      summary: Bcl-xL is involved in cellular stress responses. PMID:29507230 
        shows that "Sustained ER stress... increases RNF183 protein levels" 
        which then "interacts with Bcl-xL...and polyubiquitinates Bcl-xL for 
        degradation." Bcl-xL protein levels are regulated in response to various
        cellular stresses.
      action: MARK_AS_OVER_ANNOTATED
      reason: This term is extremely broad. While Bcl-xL is regulated by and 
        responds to various stresses, this high-level term does not capture the 
        specific molecular function. More specific terms like those for 
        apoptotic signaling pathways are preferred.
  - term:
      id: GO:0016020
      label: membrane
    evidence_type: IEA
    original_reference_id: GO_REF:0000120
    review:
      summary: Generic membrane annotation. Bcl-xL is indeed a membrane protein 
        with a C-terminal transmembrane domain. However, this is too broad - 
        more specific membrane annotations (mitochondrial outer membrane, ER 
        membrane) are already present.
      action: MARK_AS_OVER_ANNOTATED
      reason: This term is too general. More specific membrane localization 
        terms (GO:0005741 mitochondrial outer membrane, GO:0005783 endoplasmic 
        reticulum) are already annotated and provide much more informative 
        cellular component information.
  - term:
      id: GO:0030672
      label: synaptic vesicle membrane
    evidence_type: IEA
    original_reference_id: GO_REF:0000044
    review:
      summary: UniProt notes "Cytoplasmic vesicle, secretory vesicle, synaptic 
        vesicle membrane" as a localization. The deep research describes "After 
        neuronal stimulation, translocates from cytosol to synaptic vesicle and 
        mitochondrion membrane in a calmodulin-dependent manner."
      action: KEEP_AS_NON_CORE
      reason: Synaptic vesicle localization is specific to neurons and 
        represents a non-apoptotic function of Bcl-xL in regulating synaptic 
        plasticity and vesicle dynamics. This is a legitimate tissue-specific 
        localization but not the core function.
  - term:
      id: GO:0031410
      label: cytoplasmic vesicle
    evidence_type: IEA
    original_reference_id: GO_REF:0000043
    review:
      summary: Generic cytoplasmic vesicle annotation. More specific annotation 
        for synaptic vesicle membrane (GO:0030672) exists and provides better 
        precision.
      action: MARK_AS_OVER_ANNOTATED
      reason: This term is too general. The more specific synaptic vesicle 
        membrane term already captures the vesicular localization. This broad 
        term adds little information beyond what is already covered by more 
        specific annotations.
  - term:
      id: GO:0031965
      label: nuclear membrane
    evidence_type: IEA
    original_reference_id: GO_REF:0000044
    review:
      summary: UniProt notes "Nucleus membrane" as a localization. The nuclear 
        envelope is continuous with the ER, and Bcl-xL's ER localization may 
        extend to the nuclear membrane.
      action: KEEP_AS_NON_CORE
      reason: Nuclear membrane localization is likely a secondary location. The 
        primary functional sites are the mitochondrial outer membrane and ER. 
        This annotation is acceptable but represents a minor localization.
  - term:
      id: GO:0042981
      label: regulation of apoptotic process
    evidence_type: IEA
    original_reference_id: GO_REF:0000002
    review:
      summary: Core function. Bcl-xL is a central regulator of apoptosis. 
        PMID:8358789 describes it as "a bcl-2-related gene that functions as a 
        dominant regulator of apoptotic cell death." This term is accurate 
        though the more specific "negative regulation of apoptotic process" 
        (GO:0043066) would be preferred for Bcl-xL specifically.
      action: ACCEPT
      reason: Accurate annotation capturing the core regulatory function. While 
        "negative regulation" would be more precise for Bcl-xL, this general 
        regulatory term is still appropriate given that the BCL2L1 locus 
        produces both anti-apoptotic (Bcl-xL) and pro-apoptotic (Bcl-xS) 
        isoforms.
  - term:
      id: GO:0043066
      label: negative regulation of apoptotic process
    evidence_type: IEA
    original_reference_id: GO_REF:0000117
    review:
      summary: CORE FUNCTION of Bcl-xL isoform. PMID:8358789 established that 
        "bcl-xL inhibits cell death upon growth factor withdrawal at least as 
        well as bcl-2." PMID:9843949 showed "Bax-induced mitochondrial changes 
        were inhibited by recombinant Bcl-xL." This is the primary molecular 
        function of the canonical Bcl-xL isoform.
      action: ACCEPT
      reason: This is the most accurate and specific annotation for the core 
        function of Bcl-xL. The anti-apoptotic activity is mediated through 
        sequestration of pro-apoptotic BH3-only proteins and direct inhibition 
        of BAX/BAK oligomerization.
      supported_by:
        - reference_id: PMID:8358789
          supporting_text: bcl-xL inhibits cell death upon growth factor 
            withdrawal at least as well as bcl-2
        - reference_id: PMID:9843949
          supporting_text: Bax-induced mitochondrial changes were inhibited by 
            recombinant Bcl-xL
  - term:
      id: GO:0051707
      label: response to other organism
    evidence_type: IEA
    original_reference_id: GO_REF:0000117
    review:
      summary: PMID:17428862 shows SARS-CoV 7a protein "interacts with Bcl-XL" 
        and "triggers apoptosis by interfering directly with the prosurvival 
        function of Bcl-XL." Bcl-xL is targeted by viral proteins as part of 
        host-pathogen interactions. However, this is a response where Bcl-xL is 
        a target, not an active responder.
      action: MARK_AS_OVER_ANNOTATED
      reason: This annotation is too indirect. Bcl-xL is targeted by pathogens 
        (e.g., SARS-CoV 7a) but does not itself "respond" to organisms. The 
        annotation conflates being a target with being a response mechanism.
  - term:
      id: GO:0097136
      label: Bcl-2 family protein complex
    evidence_type: IEA
    original_reference_id: GO_REF:0000117
    review:
      summary: Core cellular component. Bcl-xL forms heterodimers with 
        pro-apoptotic Bcl-2 family members. PMID:9388232 describes "the 
        interactions of BAD with wild type and mutant BCL-2 and BCL-XL proteins"
        and demonstrates "human Bad interacted with BCL-2 and BCL-XL." Bcl-xL 
        binds BAX, BAK, BAD, BIM, and other BH3-only proteins.
      action: ACCEPT
      reason: Accurate annotation. Bcl-xL functions by forming complexes with 
        other Bcl-2 family proteins. This complex formation is central to its 
        molecular mechanism of action in regulating apoptosis.
      supported_by:
        - reference_id: PMID:9388232
          supporting_text: human Bad interacted with BCL-2 and BCL-XL
  - term:
      id: GO:1902531
      label: regulation of intracellular signal transduction
    evidence_type: IEA
    original_reference_id: GO_REF:0000117
    review:
      summary: Broad term. Bcl-xL does regulate signaling by controlling 
        apoptotic signal transduction. It prevents caspase activation and 
        cytochrome c release which are key signaling events.
      action: MARK_AS_OVER_ANNOTATED
      reason: This term is too broad and non-specific. More precise annotations 
        about apoptotic signaling pathway regulation are already present and 
        provide better information about the actual function.
  - term:
      id: GO:2001233
      label: regulation of apoptotic signaling pathway
    evidence_type: IEA
    original_reference_id: GO_REF:0000117
    review:
      summary: Core function. Bcl-xL regulates apoptotic signaling through its 
        interactions with pro-apoptotic proteins. This is an appropriate level 
        of annotation though more specific terms exist.
      action: ACCEPT
      reason: Accurate and appropriately specific annotation for Bcl-xL 
        function. While "negative regulation of apoptotic signaling pathway" 
        would be more precise for Bcl-xL, this term is acceptable as a parent 
        term.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:10446169
    review:
      summary: Generic protein binding annotation. Bcl-xL binds many proteins 
        including BAX, BAK, BAD, BIM, PUMA, VDAC, ATP synthase beta subunit, and
        others. These interactions should be captured by more specific MF terms.
      action: MODIFY
      reason: Per curation guidelines, "protein binding" is uninformative. 
        Bcl-xL's binding function should be annotated with more specific terms 
        like GO:0051434 "BH3 domain binding" which captures its functional 
        binding to pro-apoptotic BH3-only proteins.
      proposed_replacement_terms:
        - id: GO:0051434
          label: BH3 domain binding
      supported_by:
        - reference_id: PMID:10446169
          supporting_text: Interaction of Alzheimer's presenilin-1 and 
            presenilin-2 with Bcl-X(L).
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:11583631
    review:
      summary: Generic protein binding annotation from high-throughput study.
      action: MODIFY
      reason: Per curation guidelines, "protein binding" is uninformative. 
        Should be replaced with specific binding activity terms.
      proposed_replacement_terms:
        - id: GO:0051434
          label: BH3 domain binding
      supported_by:
        - reference_id: PMID:11583631
          supporting_text: BCL-2, BCL-X(L) sequester BH3 domain-only molecules 
            preventing BAX- and BAK-mediated mitochondrial apoptosis.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:12815463
    review:
      summary: Generic protein binding annotation.
      action: MODIFY
      reason: Per curation guidelines, "protein binding" is uninformative.
      proposed_replacement_terms:
        - id: GO:0051434
          label: BH3 domain binding
      supported_by:
        - reference_id: PMID:12815463
          supporting_text: HSpin1, a transmembrane protein interacting with 
            Bcl-2/Bcl-xL, induces a caspase-independent autophagic cell death.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:14739602
    review:
      summary: Generic protein binding annotation.
      action: MODIFY
      reason: Per curation guidelines, "protein binding" is uninformative.
      proposed_replacement_terms:
        - id: GO:0051434
          label: BH3 domain binding
      supported_by:
        - reference_id: PMID:14739602
          supporting_text: The Siva-1 putative amphipathic helical region (SAH) 
            is sufficient to bind to BCL-XL and sensitize cells to UV radiation 
            induced apoptosis.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:16189514
    review:
      summary: Generic protein binding annotation.
      action: MODIFY
      reason: Per curation guidelines, "protein binding" is uninformative.
      proposed_replacement_terms:
        - id: GO:0051434
          label: BH3 domain binding
      supported_by:
        - reference_id: PMID:16189514
          supporting_text: Towards a proteome-scale map of the human 
            protein-protein interaction network.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:16697956
    review:
      summary: Generic protein binding annotation.
      action: MODIFY
      reason: Per curation guidelines, "protein binding" is uninformative.
      proposed_replacement_terms:
        - id: GO:0051434
          label: BH3 domain binding
      supported_by:
        - reference_id: PMID:16697956
          supporting_text: Mitochondria primed by death signals determine 
            cellular addiction to antiapoptotic BCL-2 family members.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:17418785
    review:
      summary: Generic protein binding annotation.
      action: MODIFY
      reason: Per curation guidelines, "protein binding" is uninformative.
      proposed_replacement_terms:
        - id: GO:0051434
          label: BH3 domain binding
      supported_by:
        - reference_id: PMID:17418785
          supporting_text: Bcl-2 and Bcl-XL regulate proinflammatory caspase-1 
            activation by interaction with NALP1.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:17525735
    review:
      summary: Generic protein binding annotation.
      action: MODIFY
      reason: Per curation guidelines, "protein binding" is uninformative.
      proposed_replacement_terms:
        - id: GO:0051434
          label: BH3 domain binding
      supported_by:
        - reference_id: PMID:17525735
          supporting_text: May 24. ERK1/2-dependent phosphorylation of BimEL 
            promotes its rapid dissociation from Mcl-1 and Bcl-xL.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:19060904
    review:
      summary: Generic protein binding annotation.
      action: MODIFY
      reason: Per curation guidelines, "protein binding" is uninformative.
      proposed_replacement_terms:
        - id: GO:0051434
          label: BH3 domain binding
      supported_by:
        - reference_id: PMID:19060904
          supporting_text: An empirical framework for binary interactome 
            mapping.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:19180116
    review:
      summary: Generic protein binding annotation.
      action: MODIFY
      reason: Per curation guidelines, "protein binding" is uninformative.
      proposed_replacement_terms:
        - id: GO:0051434
          label: BH3 domain binding
      supported_by:
        - reference_id: PMID:19180116
          supporting_text: DAP-kinase-mediated phosphorylation on the BH3 domain
            of beclin 1 promotes dissociation of beclin 1 from Bcl-XL and 
            induction of autophagy.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:19427857
    review:
      summary: Generic protein binding annotation.
      action: MODIFY
      reason: Per curation guidelines, "protein binding" is uninformative.
      proposed_replacement_terms:
        - id: GO:0051434
          label: BH3 domain binding
      supported_by:
        - reference_id: PMID:19427857
          supporting_text: Epub 2009 May 8. Transcriptomic and proteomic 
            approach to studying SNX-2112-induced K562 cells apoptosis and 
            anti-leukemia activity in K562-NOD/SCID mice.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:21988832
    review:
      summary: Generic protein binding annotation.
      action: MODIFY
      reason: Per curation guidelines, "protein binding" is uninformative.
      proposed_replacement_terms:
        - id: GO:0051434
          label: BH3 domain binding
      supported_by:
        - reference_id: PMID:21988832
          supporting_text: Toward an understanding of the protein interaction 
            network of the human liver.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:25241761
    review:
      summary: Generic protein binding annotation.
      action: MODIFY
      reason: Per curation guidelines, "protein binding" is uninformative.
      proposed_replacement_terms:
        - id: GO:0051434
          label: BH3 domain binding
      supported_by:
        - reference_id: PMID:25241761
          supporting_text: Oct 9. Using an in situ proximity ligation assay to 
            systematically profile endogenous protein-protein interactions in a 
            pathway network.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:25416956
    review:
      summary: Generic protein binding annotation.
      action: MODIFY
      reason: Per curation guidelines, "protein binding" is uninformative.
      proposed_replacement_terms:
        - id: GO:0051434
          label: BH3 domain binding
      supported_by:
        - reference_id: PMID:25416956
          supporting_text: A proteome-scale map of the human interactome 
            network.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:26871637
    review:
      summary: Generic protein binding annotation.
      action: MODIFY
      reason: Per curation guidelines, "protein binding" is uninformative.
      proposed_replacement_terms:
        - id: GO:0051434
          label: BH3 domain binding
      supported_by:
        - reference_id: PMID:26871637
          supporting_text: Widespread Expansion of Protein Interaction 
            Capabilities by Alternative Splicing.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:27107012
    review:
      summary: Generic protein binding annotation.
      action: MODIFY
      reason: Per curation guidelines, "protein binding" is uninformative.
      proposed_replacement_terms:
        - id: GO:0051434
          label: BH3 domain binding
      supported_by:
        - reference_id: PMID:27107012
          supporting_text: Pooled-matrix protein interaction screens using 
            Barcode Fusion Genetics.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:29997244
    review:
      summary: Generic protein binding annotation.
      action: MODIFY
      reason: Per curation guidelines, "protein binding" is uninformative.
      proposed_replacement_terms:
        - id: GO:0051434
          label: BH3 domain binding
      supported_by:
        - reference_id: PMID:29997244
          supporting_text: 'LuTHy: a double-readout bioluminescence-based two-hybrid
            technology for quantitative mapping of protein-protein interactions in
            mammalian cells.'
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:31467278
    review:
      summary: Generic protein binding annotation.
      action: MODIFY
      reason: Per curation guidelines, "protein binding" is uninformative.
      proposed_replacement_terms:
        - id: GO:0051434
          label: BH3 domain binding
      supported_by:
        - reference_id: PMID:31467278
          supporting_text: Maximizing binary interactome mapping with a minimal 
            number of assays.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:31515488
    review:
      summary: Generic protein binding annotation.
      action: MODIFY
      reason: Per curation guidelines, "protein binding" is uninformative.
      proposed_replacement_terms:
        - id: GO:0051434
          label: BH3 domain binding
      supported_by:
        - reference_id: PMID:31515488
          supporting_text: Extensive disruption of protein interactions by 
            genetic variants across the allele frequency spectrum in human 
            populations.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:31980649
    review:
      summary: Generic protein binding annotation.
      action: MODIFY
      reason: Per curation guidelines, "protein binding" is uninformative.
      proposed_replacement_terms:
        - id: GO:0051434
          label: BH3 domain binding
      supported_by:
        - reference_id: PMID:31980649
          supporting_text: Extensive rewiring of the EGFR network in colorectal 
            cancer cells expressing transforming levels of KRAS(G13D).
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:32296183
    review:
      summary: Generic protein binding annotation.
      action: MODIFY
      reason: Per curation guidelines, "protein binding" is uninformative.
      proposed_replacement_terms:
        - id: GO:0051434
          label: BH3 domain binding
      supported_by:
        - reference_id: PMID:32296183
          supporting_text: Apr 8. A reference map of the human binary protein 
            interactome.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:32814053
    review:
      summary: Generic protein binding annotation.
      action: MODIFY
      reason: Per curation guidelines, "protein binding" is uninformative.
      proposed_replacement_terms:
        - id: GO:0051434
          label: BH3 domain binding
      supported_by:
        - reference_id: PMID:32814053
          supporting_text: Interactome Mapping Provides a Network of 
            Neurodegenerative Disease Proteins and Uncovers Widespread Protein 
            Aggregation in Affected Brains.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:33961781
    review:
      summary: Generic protein binding annotation.
      action: MODIFY
      reason: Per curation guidelines, "protein binding" is uninformative.
      proposed_replacement_terms:
        - id: GO:0051434
          label: BH3 domain binding
      supported_by:
        - reference_id: PMID:33961781
          supporting_text: 2021 May 6. Dual proteome-scale networks reveal 
            cell-specific remodeling of the human interactome.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:35512704
    review:
      summary: Generic protein binding annotation.
      action: MODIFY
      reason: Per curation guidelines, "protein binding" is uninformative.
      proposed_replacement_terms:
        - id: GO:0051434
          label: BH3 domain binding
      supported_by:
        - reference_id: PMID:35512704
          supporting_text: 2022 May 4. Systematic discovery of mutation-directed
            neo-protein-protein interactions in cancer.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:37398436
    review:
      summary: Generic protein binding annotation.
      action: MODIFY
      reason: Per curation guidelines, "protein binding" is uninformative.
      proposed_replacement_terms:
        - id: GO:0051434
          label: BH3 domain binding
      supported_by:
        - reference_id: PMID:37398436
          supporting_text: AI-guided pipeline for protein-protein interaction 
            drug discovery identifies a SARS-CoV-2 inhibitor.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:40205054
    review:
      summary: Generic protein binding annotation.
      action: MODIFY
      reason: Per curation guidelines, "protein binding" is uninformative.
      proposed_replacement_terms:
        - id: GO:0051434
          label: BH3 domain binding
      supported_by:
        - reference_id: PMID:40205054
          supporting_text: Apr 9. Multimodal cell maps as a foundation for 
            structural and functional genomics.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:9305851
    review:
      summary: Generic protein binding annotation.
      action: MODIFY
      reason: Per curation guidelines, "protein binding" is uninformative.
      proposed_replacement_terms:
        - id: GO:0051434
          label: BH3 domain binding
      supported_by:
        - reference_id: PMID:9305851
          supporting_text: BH3 domain of BAD is required for heterodimerization 
            with BCL-XL and pro-apoptotic activity.
  - term:
      id: GO:0042802
      label: identical protein binding
    evidence_type: IPI
    original_reference_id: PMID:21856303
    review:
      summary: Bcl-xL can homodimerize. PMID:21856303 demonstrates 
        homodimerization of Bcl-xL. The deep research notes "Bcl-xL can form 
        homodimers under specific conditions" and domain-swapped dimers have 
        been observed crystallographically.
      action: KEEP_AS_NON_CORE
      reason: Homodimerization is a secondary activity. The primary molecular 
        function involves heterodimerization with pro-apoptotic Bcl-2 family 
        members (BAX, BAK, BH3-only proteins). Homodimerization may be relevant 
        but is not the core functional interaction.
      supported_by:
        - reference_id: PMID:21856303
          supporting_text: Epub 2011 Aug 16. Protein oligomerization mediated by
            the transmembrane carboxyl terminal domain of Bcl-XL.
  - term:
      id: GO:0005739
      label: mitochondrion
    evidence_type: IEA
    original_reference_id: GO_REF:0000107
    review:
      summary: Core localization. Mitochondrion is the primary functional site 
        for Bcl-xL. More specific term (mitochondrial outer membrane, 
        GO:0005741) is already annotated and preferred.
      action: ACCEPT
      reason: Valid localization. While more specific terms exist, this general 
        term is acceptable as a parent annotation for mitochondrial 
        localization.
  - term:
      id: GO:0005783
      label: endoplasmic reticulum
    evidence_type: IEA
    original_reference_id: GO_REF:0000107
    review:
      summary: Secondary localization. UniProt notes ER localization. 
        PMID:17428862 showed "fractionation experiments showed that 7a 
        colocalized with Bcl-XL at the endoplasmic reticulum as well as the 
        mitochondria." Bcl-xL regulates ER calcium stores and ER stress-induced 
        apoptosis.
      action: ACCEPT
      reason: Valid secondary localization. The ER is an important site for 
        Bcl-xL function, particularly in calcium regulation and ER stress 
        responses.
      supported_by:
        - reference_id: PMID:17428862
          supporting_text: fractionation experiments showed that 7a colocalized 
            with Bcl-XL at the endoplasmic reticulum as well as the mitochondria
  - term:
      id: GO:0031966
      label: mitochondrial membrane
    evidence_type: IEA
    original_reference_id: GO_REF:0000107
    review:
      summary: Valid but less specific than GO:0005741 (mitochondrial outer 
        membrane) which is already annotated.
      action: ACCEPT
      reason: Valid annotation but less informative than the more specific MOM 
        annotation. Acceptable as a parent term.
  - term:
      id: GO:0005739
      label: mitochondrion
    evidence_type: HTP
    original_reference_id: PMID:34800366
    review:
      summary: High-throughput evidence supporting mitochondrial localization. 
        Consistent with other annotations and well-established biology.
      action: ACCEPT
      reason: Additional evidence supporting the well-established mitochondrial 
        localization.
      supported_by:
        - reference_id: PMID:34800366
          supporting_text: Epub 2021 Nov 19. Quantitative high-confidence human 
            mitochondrial proteome and its dynamics in cellular context.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:22498477
    review:
      summary: Generic protein binding annotation.
      action: MODIFY
      reason: Per curation guidelines, "protein binding" is uninformative.
      proposed_replacement_terms:
        - id: GO:0051434
          label: BH3 domain binding
      supported_by:
        - reference_id: PMID:22498477
          supporting_text: The anti-apoptotic Bcl-B protein inhibits 
            BECN1-dependent autophagic cell death.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:17428862
    review:
      summary: This IPI annotation from PMID:17428862 demonstrates Bcl-xL 
        binding to SARS-CoV 7a protein. "Coimmunoprecipitation experiments 
        showed that 7a interacts with Bcl-XL and other prosurvival proteins."
      action: MODIFY
      reason: Per curation guidelines, "protein binding" is uninformative. This 
        interaction is with a viral protein, not a BH3 domain-containing 
        protein.
      proposed_replacement_terms:
        - id: GO:0046790
          label: virion binding
      supported_by:
        - reference_id: PMID:17428862
          supporting_text: Induction of apoptosis by the severe acute 
            respiratory syndrome coronavirus 7a protein is dependent on its 
            interaction with the Bcl-XL protein.
  - term:
      id: GO:0051607
      label: defense response to virus
    evidence_type: IDA
    original_reference_id: PMID:17428862
    review:
      summary: PMID:17428862 shows that "overexpression of Bcl-XL blocks 
        7a-induced apoptosis" from SARS-CoV. However, Bcl-xL is the TARGET of 
        viral manipulation, not an active defender. The virus 7a protein 
        interferes with Bcl-xL to induce apoptosis.
      action: REMOVE
      reason: This annotation is incorrect. Bcl-xL does not mount a defense 
        response to virus; rather, it is targeted BY the virus (SARS-CoV 7a) to 
        subvert host cell survival. The paper shows 7a "triggers apoptosis by 
        interfering directly with the prosurvival function of Bcl-XL." Being 
        targeted by a pathogen is not the same as participating in defense 
        response.
      supported_by:
        - reference_id: PMID:17428862
          supporting_text: Induction of apoptosis by the severe acute 
            respiratory syndrome coronavirus 7a protein is dependent on its 
            interaction with the Bcl-XL protein.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:20541605
    review:
      summary: Generic protein binding annotation.
      action: MODIFY
      reason: Per curation guidelines, "protein binding" is uninformative.
      proposed_replacement_terms:
        - id: GO:0051434
          label: BH3 domain binding
      supported_by:
        - reference_id: PMID:20541605
          supporting_text: Epub 2010 Jun 10. RACK1 promotes Bax oligomerization 
            and dissociates the interaction of Bax and Bcl-XL.
  - term:
      id: GO:1902236
      label: negative regulation of endoplasmic reticulum stress-induced 
        intrinsic apoptotic signaling pathway
    evidence_type: IDA
    original_reference_id: PMID:29507230
    review:
      summary: IMPORTANT IDA annotation. PMID:29507230 shows that Bcl-xL is 
        degraded during ER stress by RNF183, which promotes apoptosis. The paper
        demonstrates that "RNF183 interacts with Bcl-xL... and polyubiquitinates
        Bcl-xL for degradation" and "Bcl-xL plays a protective role against ER 
        stress-induced apoptosis." When Bcl-xL levels are maintained, it 
        negatively regulates ER stress-induced apoptosis.
      action: ACCEPT
      reason: Accurate and appropriately specific annotation. The paper directly
        demonstrates Bcl-xL's protective role against ER stress-induced 
        apoptosis by showing that its degradation correlates with increased 
        apoptosis.
      supported_by:
        - reference_id: PMID:29507230
          supporting_text: overexpression of RNF183 leads to increased apoptosis
            and its depletion alleviates ER stress-induced apoptosis... RNF183 
            interacts with Bcl-xL, an antiapoptotic member of the Bcl-2 family, 
            and polyubiquitinates Bcl-xL for degradation
  - term:
      id: GO:0032465
      label: regulation of cytokinesis
    evidence_type: IMP
    original_reference_id: PMID:21840391
    review:
      summary: Non-apoptotic function of Bcl-xL. PMID:21840391 demonstrates that
        "cells expressing Bcl-xL(Ser49Ala) mutant... enter cytokinesis more 
        slowly after microtubule poisoning" and "These effects of 
        Bcl-xL(Ser49Ala) mutant seem to be separable from Bcl-xL function in 
        apoptosis." During telophase/cytokinesis, phospho-Bcl-xL(Ser49) is found
        with dynein motor protein.
      action: KEEP_AS_NON_CORE
      reason: Valid annotation for a non-apoptotic function. The paper clearly 
        demonstrates Bcl-xL's role in cytokinesis timing, independent of its 
        apoptotic function. This is a legitimate secondary function but not the 
        core role.
      supported_by:
        - reference_id: PMID:21840391
          supporting_text: cells expressing Bcl-xL(Ser49Ala) mutant are less 
            stable at G2 checkpoint after DNA damage and enter cytokinesis more 
            slowly after microtubule poisoning, than cells expressing wild-type 
            Bcl-xL. These effects of Bcl-xL(Ser49Ala) mutant seem to be 
            separable from Bcl-xL function in apoptosis
  - term:
      id: GO:1902042
      label: negative regulation of extrinsic apoptotic signaling pathway via 
        death domain receptors
    evidence_type: IDA
    original_reference_id: PMID:26582200
    review:
      summary: PMID:26582200 shows "LFG protects only type II apoptotic cells 
        from FasL-induced death in a Bcl-XL dependent manner." The paper 
        demonstrates that Bcl-xL is essential for protecting against Fas 
        ligand-induced apoptosis in type II cells. "We further investigated the 
        relationship between LFG and Bcl-XL in the inhibition of apoptosis."
      action: ACCEPT
      reason: Accurate annotation. The paper shows Bcl-xL negatively regulates 
        FasL-induced apoptosis (death receptor pathway) in type II apoptotic 
        cells. This is well-supported and represents a core anti-apoptotic 
        function.
      supported_by:
        - reference_id: PMID:26582200
          supporting_text: LFG protects only type II apoptotic cells from 
            FasL-induced death in a Bcl-XL dependent manner... we show by 
            co-immunoprecipitation experiments that LFG interacts with Bcl-XL 
            and Bcl-2
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:27013495
    review:
      summary: Generic protein binding annotation.
      action: MODIFY
      reason: Per curation guidelines, "protein binding" is uninformative.
      proposed_replacement_terms:
        - id: GO:0051434
          label: BH3 domain binding
      supported_by:
        - reference_id: PMID:27013495
          supporting_text: The deubiquitinase Usp27x stabilizes the BH3-only 
            protein Bim and enhances apoptosis.
  - term:
      id: GO:0005829
      label: cytosol
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-9698026
    review:
      summary: Reactome-derived cytosol annotation. Consistent with IEA 
        annotation.
      action: ACCEPT
      reason: Valid localization supported by Reactome pathways. A cytosolic 
        pool of Bcl-xL exists prior to membrane insertion.
  - term:
      id: GO:0005829
      label: cytosol
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-9704655
    review:
      summary: Reactome-derived cytosol annotation. Duplicate.
      action: ACCEPT
      reason: Valid localization, duplicate annotation from Reactome.
  - term:
      id: GO:0005829
      label: cytosol
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-9704692
    review:
      summary: Reactome-derived cytosol annotation. Duplicate.
      action: ACCEPT
      reason: Valid localization, duplicate annotation from Reactome.
  - term:
      id: GO:0005829
      label: cytosol
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-9796043
    review:
      summary: Reactome-derived cytosol annotation. Duplicate.
      action: ACCEPT
      reason: Valid localization, duplicate annotation from Reactome.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:25296756
    review:
      summary: Generic protein binding annotation.
      action: MODIFY
      reason: Per curation guidelines, "protein binding" is uninformative.
      proposed_replacement_terms:
        - id: GO:0051434
          label: BH3 domain binding
      supported_by:
        - reference_id: PMID:25296756
          supporting_text: 2014 Oct 8. Plasminogen kringle 5 induces endothelial
            cell apoptosis by triggering a voltage-dependent anion channel 1 
            (VDAC1) positive feedback loop.
  - term:
      id: GO:0051434
      label: BH3 domain binding
    evidence_type: IPI
    original_reference_id: PMID:21639858
    review:
      summary: CORE MOLECULAR FUNCTION. PMID:21639858 provides structural 
        evidence of Bcl-xL binding BH3 domains. "We provide NMR, SPR and 
        crystallographic evidence that a peptide spanning residues 147-172 in 
        SOUL interacts with the anti-apoptotic protein Bcl-xL." The paper solved
        the "complex of its BH3 domain peptide with Bcl-xL."
      action: ACCEPT
      reason: This is the CORE molecular function of Bcl-xL. The BH3-binding 
        groove binds BH3 domains from pro-apoptotic proteins (BAX, BAK, BAD, 
        BIM, PUMA, NOXA, etc.), which is the molecular basis for Bcl-xL's 
        anti-apoptotic activity.
      supported_by:
        - reference_id: PMID:21639858
          supporting_text: In the present study, we provide NMR, SPR (surface 
            plasmon resonance) and crystallographic evidence that a peptide 
            spanning residues 147-172 in SOUL interacts with the anti-apoptotic 
            protein Bcl-xL
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:11060313
    review:
      summary: Generic protein binding annotation.
      action: MODIFY
      reason: Per curation guidelines, "protein binding" is uninformative.
      proposed_replacement_terms:
        - id: GO:0051434
          label: BH3 domain binding
      supported_by:
        - reference_id: PMID:11060313
          supporting_text: Nov 1. MAP-1, a novel proapoptotic protein containing
            a BH3-like motif that associates with Bax through its Bcl-2 homology
            domains.
  - term:
      id: GO:1902230
      label: negative regulation of intrinsic apoptotic signaling pathway in 
        response to DNA damage
    evidence_type: IDA
    original_reference_id: PMID:16608847
    review:
      summary: Core function. PMID:16608847 shows "Bcl-X(L) was most effective 
        among several antiapoptotic proteins in suppressing PUMA-induced 
        apoptosis and PUMA-dependent apoptosis induced by the DNA-damaging agent
        adriamycin." PUMA is induced by p53 in response to DNA damage.
      action: ACCEPT
      reason: Accurate annotation for core function. Bcl-xL protects cells from 
        DNA damage-induced apoptosis by sequestering PUMA and preventing BAX 
        activation.
      supported_by:
        - reference_id: PMID:16608847
          supporting_text: Bcl-X(L) was most effective among several 
            antiapoptotic proteins in suppressing PUMA-induced apoptosis and 
            PUMA-dependent apoptosis induced by the DNA-damaging agent 
            adriamycin
  - term:
      id: GO:2001240
      label: negative regulation of extrinsic apoptotic signaling pathway in 
        absence of ligand
    evidence_type: TAS
    original_reference_id: PMID:8358789
    review:
      summary: 'CORE FUNCTION. PMID:8358789 is the foundational paper: "bcl-xL inhibits
        cell death upon growth factor withdrawal." This refers to the extrinsic pathway
        where absence of survival ligand (growth factor) triggers apoptosis.'
      action: ACCEPT
      reason: Core anti-apoptotic function. This is exactly what the 
        foundational paper demonstrated.
      supported_by:
        - reference_id: PMID:8358789
          supporting_text: bcl-xL inhibits cell death upon growth factor 
            withdrawal at least as well as bcl-2
  - term:
      id: GO:1900118
      label: negative regulation of execution phase of apoptosis
    evidence_type: IDA
    original_reference_id: PMID:20673843
    review:
      summary: PMID:20673843 shows "loss of Bcl-X(L) increases apoptosis in 
        human granulosa tumour cell line." The execution phase involves caspase 
        activation and cytochrome c release, both of which Bcl-xL inhibits by 
        preventing mitochondrial outer membrane permeabilization.
      action: ACCEPT
      reason: Accurate annotation. By preventing MOMP, Bcl-xL blocks the 
        execution phase of apoptosis.
      supported_by:
        - reference_id: PMID:20673843
          supporting_text: loss of Bcl-X(L) increases apoptosis in human 
            granulosa tumour cell line
  - term:
      id: GO:2001243
      label: negative regulation of intrinsic apoptotic signaling pathway
    evidence_type: IDA
    original_reference_id: PMID:12011449
    review:
      summary: PMID:12011449 shows "Siva-1 binds to and inhibits 
        BCL-X(L)-mediated protection against UV radiation-induced apoptosis." 
        The paper demonstrates Bcl-xL protects against UV-induced apoptosis 
        (intrinsic pathway). "BCL-X(L) promotes survival."
      action: ACCEPT
      reason: Core function. Bcl-xL negatively regulates intrinsic apoptosis by 
        binding and sequestering pro-apoptotic proteins and preventing MOMP.
      supported_by:
        - reference_id: PMID:12011449
          supporting_text: Siva-1 binds to and inhibits BCL-X(L)-mediated 
            protection against UV radiation-induced apoptosis
  - term:
      id: GO:0005741
      label: mitochondrial outer membrane
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-508162
    review:
      summary: Reactome-derived MOM annotation. Core localization.
      action: ACCEPT
      reason: Valid localization, consistent with IBA and IEA annotations.
  - term:
      id: GO:0005741
      label: mitochondrial outer membrane
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-6790025
    review:
      summary: Reactome-derived MOM annotation. Duplicate.
      action: ACCEPT
      reason: Valid localization, consistent with other MOM annotations.
  - term:
      id: GO:0005741
      label: mitochondrial outer membrane
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-879201
    review:
      summary: Reactome-derived MOM annotation. Duplicate.
      action: ACCEPT
      reason: Valid localization, consistent with other MOM annotations.
  - term:
      id: GO:0005741
      label: mitochondrial outer membrane
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-9653595
    review:
      summary: Reactome-derived MOM annotation. Duplicate.
      action: ACCEPT
      reason: Valid localization, consistent with other MOM annotations.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:11714801
    review:
      summary: Generic protein binding annotation.
      action: MODIFY
      reason: Per curation guidelines, protein binding is uninformative.
      proposed_replacement_terms:
        - id: GO:0051434
          label: BH3 domain binding
      supported_by:
        - reference_id: PMID:11714801
          supporting_text: The association of Aiolos transcription factor and 
            Bcl-xL is involved in the control of apoptosis.
  - term:
      id: GO:0005813
      label: centrosome
    evidence_type: IDA
    original_reference_id: PMID:21840391
    review:
      summary: PMID:21840391 demonstrates centrosome localization of 
        phospho-Bcl-xL(Ser49) during G2 checkpoint. This is conditional 
        localization related to cell cycle function.
      action: KEEP_AS_NON_CORE
      reason: Non-core localization associated with cell cycle checkpoint 
        function, not the primary anti-apoptotic function.
      supported_by:
        - reference_id: PMID:21840391
          supporting_text: 2011 Aug 5. Bcl-xL phosphorylation at Ser49 by polo 
            kinase 3 during cell cycle progression and checkpoints.
  - term:
      id: GO:0019901
      label: protein kinase binding
    evidence_type: IPI
    original_reference_id: PMID:21840391
    review:
      summary: PMID:21840391 shows Bcl-xL is phosphorylated by PLK3. The paper 
        demonstrates "polo kinase 3 (PLK3) was implicated in Bcl-xL(Ser49) 
        phosphorylation."
      action: KEEP_AS_NON_CORE
      reason: Valid interaction but represents a regulatory mechanism rather 
        than core function. Bcl-xL is a substrate/binding partner of PLK3 for 
        its cell cycle-related functions.
      supported_by:
        - reference_id: PMID:21840391
          supporting_text: 2011 Aug 5. Bcl-xL phosphorylation at Ser49 by polo 
            kinase 3 during cell cycle progression and checkpoints.
  - term:
      id: GO:0097136
      label: Bcl-2 family protein complex
    evidence_type: IDA
    original_reference_id: PMID:21199865
    review:
      summary: PMID:21199865 describes crystal structures of Bcl-xL in complex 
        with Bax BH3 peptide. "Crystal structures of the pro-survival proteins 
        Mcl-1 and Bcl-x(L) in complex with a 34-mer peptide from Bax."
      action: ACCEPT
      reason: Core cellular component. Bcl-xL forms complexes with other Bcl-2 
        family members.
      supported_by:
        - reference_id: PMID:21199865
          supporting_text: 2011 Jan 3. Mutation to Bax beyond the BH3 domain 
            disrupts interactions with pro-survival proteins and promotes 
            apoptosis.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:21081150
    review:
      summary: Generic protein binding annotation.
      action: MODIFY
      reason: Per curation guidelines, protein binding is uninformative.
      proposed_replacement_terms:
        - id: GO:0051434
          label: BH3 domain binding
      supported_by:
        - reference_id: PMID:21081150
          supporting_text: Pore-forming activity of BAD is regulated by specific
            phosphorylation and structural transitions of the C-terminal part.
  - term:
      id: GO:0043066
      label: negative regulation of apoptotic process
    evidence_type: IDA
    original_reference_id: PMID:9388232
    review:
      summary: CORE FUNCTION of Bcl-xL isoform (Q07817-1). PMID:9388232 
        demonstrates that BCL-XL heterodimerizes with the pro-apoptotic protein 
        BAD through BH3 domain interactions. This binding sequesters BAD and 
        prevents it from promoting apoptosis. The paper states "human Bad 
        interacted with BCL-2 and BCL-XL" and shows this interaction is mediated
        by the BH3 domain.
      action: ACCEPT
      reason: 'Core anti-apoptotic function of Bcl-xL. The mechanism involves sequestering
        pro-apoptotic BH3-only proteins like BAD. Note: This function is specific
        to Bcl-xL (Q07817-1), not the pro-apoptotic Bcl-xS isoform (Q07817-2).'
      supported_by:
        - reference_id: PMID:9388232
          supporting_text: human Bad interacted with BCL-2 and BCL-XL
  - term:
      id: GO:0090201
      label: negative regulation of release of cytochrome c from mitochondria
    evidence_type: IC
    original_reference_id: PMID:21041309
    review:
      summary: Core function. Bcl-xL prevents cytochrome c release by inhibiting
        BAX/BAK-mediated MOMP. PMID:21041309 shows that "Bcl-xL-type 
        anti-apoptotic proteins were inhibited" correlates with cytochrome c 
        release.
      action: ACCEPT
      reason: Core anti-apoptotic function. Preventing cytochrome c release is 
        the key mechanism by which Bcl-xL inhibits apoptosis.
      supported_by:
        - reference_id: PMID:21041309
          supporting_text: 2010 Nov 1. BH3 domains other than Bim and Bid can 
            directly activate Bax/Bak.
  - term:
      id: GO:1903077
      label: negative regulation of protein localization to plasma membrane
    evidence_type: IDA
    original_reference_id: PMID:21041309
    review:
      summary: PMID:21041309 demonstrates Bcl-xL prevents BAX translocation. 
        This refers to BAX moving to mitochondria, not plasma membrane. The 
        annotation appears questionable.
      action: UNDECIDED
      reason: Unable to verify this specific annotation from the publication 
        abstract. The paper discusses BAX mitochondrial localization, not plasma
        membrane. May need full text review to confirm.
      supported_by:
        - reference_id: PMID:21041309
          supporting_text: 2010 Nov 1. BH3 domains other than Bim and Bid can 
            directly activate Bax/Bak.
  - term:
      id: GO:0005737
      label: cytoplasm
    evidence_type: IDA
    original_reference_id: PMID:20673843
    review:
      summary: Cytoplasmic localization is valid. More specific annotations 
        exist.
      action: ACCEPT
      reason: Valid but non-specific localization. Bcl-xL is found in cytoplasm 
        as well as various membrane compartments.
      supported_by:
        - reference_id: PMID:20673843
          supporting_text: Regulation of cell death in human fetal and adult 
            ovaries--role of Bok and Bcl-X(L).
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:15110758
    review:
      summary: Generic protein binding annotation.
      action: MODIFY
      reason: Per curation guidelines, protein binding is uninformative.
      proposed_replacement_terms:
        - id: GO:0051434
          label: BH3 domain binding
      supported_by:
        - reference_id: PMID:15110758
          supporting_text: FAST is a BCL-X(L)-associated mitochondrial protein.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:20010695
    review:
      summary: Generic protein binding annotation.
      action: MODIFY
      reason: Per curation guidelines, protein binding is uninformative.
      proposed_replacement_terms:
        - id: GO:0051434
          label: BH3 domain binding
      supported_by:
        - reference_id: PMID:20010695
          supporting_text: Antagonism of Beclin 1-dependent autophagy by BCL-2 
            at the endoplasmic reticulum requires NAF-1.
  - term:
      id: GO:0034097
      label: response to cytokine
    evidence_type: IDA
    original_reference_id: PMID:9184696
    review:
      summary: Bcl-xL expression is regulated by cytokines. IL-2 withdrawal 
        leads to decreased Bcl-x expression and apoptosis. However, Bcl-xL 
        itself does not "respond" to cytokines - its expression is regulated by 
        them.
      action: MARK_AS_OVER_ANNOTATED
      reason: Imprecise annotation. Bcl-xL levels are regulated by cytokine 
        signaling, but the protein itself is not a cytokine responder. This 
        conflates transcriptional regulation with protein function.
      supported_by:
        - reference_id: PMID:9184696
          supporting_text: The apoptosis and proliferation of SAC-activated B 
            cells by IL-10 are associated with changes in Bcl-2, Bcl-xL, and 
            Mcl-1 expression.
  - term:
      id: GO:0043066
      label: negative regulation of apoptotic process
    evidence_type: IDA
    original_reference_id: PMID:7650367
    review:
      summary: CORE FUNCTION of Bcl-xL isoform (Q07817-1). PMID:7650367 directly
        demonstrates that "Stable transfection of either bcl-2 or bcl-x 
        expression plasmids promotes the survival of CTLL-2 cells in the setting
        of IL-2 withdrawal" with "Over 70 to 90% of the transfected cells remain
        viable at 48 h after IL-2 withdrawal when all of the control transfected
        cells are apoptotic."
      action: ACCEPT
      reason: Strong experimental evidence that Bcl-x (Bcl-xL) inhibits 
        apoptosis. The paper shows bcl-x expression protects cells from IL-2 
        withdrawal-induced apoptosis.
      supported_by:
        - reference_id: PMID:7650367
          supporting_text: Stable transfection of either bcl-2 or bcl-x 
            expression plasmids promotes the survival of CTLL-2 cells in the 
            setting of IL-2 withdrawal
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:14752512
    review:
      summary: Generic protein binding annotation.
      action: MODIFY
      reason: Per curation guidelines, protein binding is uninformative.
      proposed_replacement_terms:
        - id: GO:0051434
          label: BH3 domain binding
      supported_by:
        - reference_id: PMID:14752512
          supporting_text: Human alphaA- and alphaB-crystallins bind to Bax and 
            Bcl-X(S) to sequester their translocation during 
            staurosporine-induced apoptosis.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:10837489
    review:
      summary: Generic protein binding annotation.
      action: MODIFY
      reason: Per curation guidelines, protein binding is uninformative.
      proposed_replacement_terms:
        - id: GO:0051434
          label: BH3 domain binding
      supported_by:
        - reference_id: PMID:10837489
          supporting_text: MCL-1S, a splicing variant of the antiapoptotic BCL-2
            family member MCL-1, encodes a proapoptotic protein possessing only 
            the BH3 domain.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:11278245
    review:
      summary: Generic protein binding annotation.
      action: MODIFY
      reason: Per curation guidelines, protein binding is uninformative.
      proposed_replacement_terms:
        - id: GO:0051434
          label: BH3 domain binding
      supported_by:
        - reference_id: PMID:11278245
          supporting_text: 2001 Feb 21. Bcl-B, a novel Bcl-2 family member that 
            differentially binds and regulates Bax and Bak.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:16608847
    review:
      summary: PMID:16608847 shows Bcl-xL binds BAX. "Bax was found to be 
        dissociated preferentially from Bcl-X(L) in HCT116 cells."
      action: MODIFY
      reason: Per curation guidelines, protein binding is uninformative. Should 
        use BH3 domain binding.
      proposed_replacement_terms:
        - id: GO:0051434
          label: BH3 domain binding
      supported_by:
        - reference_id: PMID:16608847
          supporting_text: 2006 Apr 11. PUMA Dissociates Bax and Bcl-X(L) to 
            induce apoptosis in colon cancer cells.
  - term:
      id: GO:0001836
      label: release of cytochrome c from mitochondria
    evidence_type: IDA
    original_reference_id: PMID:9843949
    review:
      summary: PMID:9843949 shows Bcl-xL INHIBITS cytochrome c release. 
        "Bax-induced mitochondrial changes were inhibited by recombinant 
        Bcl-xL."
      action: MODIFY
      reason: The term implies Bcl-xL promotes cytochrome c release, but it 
        actually INHIBITS it. Should be GO:0090201 (negative regulation of 
        release of cytochrome c).
      proposed_replacement_terms:
        - id: GO:0090201
          label: negative regulation of release of cytochrome c from 
            mitochondria
      supported_by:
        - reference_id: PMID:9843949
          supporting_text: Bax interacts with the permeability transition pore 
            to induce permeability transition and cytochrome c release in 
            isolated mitochondria.
  - term:
      id: GO:0046902
      label: regulation of mitochondrial membrane permeability
    evidence_type: IDA
    original_reference_id: PMID:9843949
    review:
      summary: PMID:9843949 shows Bcl-xL regulates mitochondrial membrane 
        permeability by inhibiting BAX-induced permeability transition.
      action: ACCEPT
      reason: Core function. Bcl-xL regulates MOM permeability by preventing 
        BAX/BAK-mediated pore formation.
      supported_by:
        - reference_id: PMID:9843949
          supporting_text: Bax interacts with the permeability transition pore 
            to induce permeability transition and cytochrome c release in 
            isolated mitochondria.
  - term:
      id: GO:0051881
      label: regulation of mitochondrial membrane potential
    evidence_type: IDA
    original_reference_id: PMID:9843949
    review:
      summary: PMID:9843949 demonstrates Bcl-xL prevents "mitochondrial Deltapsi
        loss" induced by BAX.
      action: ACCEPT
      reason: Core function. Maintaining mitochondrial membrane potential is 
        part of the anti-apoptotic mechanism.
      supported_by:
        - reference_id: PMID:9843949
          supporting_text: Bax interacts with the permeability transition pore 
            to induce permeability transition and cytochrome c release in 
            isolated mitochondria.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:12011449
    review:
      summary: PMID:12011449 shows Bcl-xL binds Siva-1 via the SAH domain. This 
        is a specific interaction that should be annotated more precisely.
      action: MODIFY
      reason: Per curation guidelines, protein binding is uninformative.
      proposed_replacement_terms:
        - id: GO:0051434
          label: BH3 domain binding
      supported_by:
        - reference_id: PMID:12011449
          supporting_text: Siva-1 binds to and inhibits BCL-X(L)-mediated 
            protection against UV radiation-induced apoptosis.
  - term:
      id: GO:0005739
      label: mitochondrion
    evidence_type: IDA
    original_reference_id: PMID:12011449
    review:
      summary: PMID:12011449 shows Siva-1/Bcl-xL complexes localize to 
        mitochondria in thymocytes.
      action: ACCEPT
      reason: Valid core localization.
      supported_by:
        - reference_id: PMID:12011449
          supporting_text: Siva-1 binds to and inhibits BCL-X(L)-mediated 
            protection against UV radiation-induced apoptosis.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:11971963
    review:
      summary: Generic protein binding annotation.
      action: MODIFY
      reason: Per curation guidelines, protein binding is uninformative.
      proposed_replacement_terms:
        - id: GO:0051434
          label: BH3 domain binding
      supported_by:
        - reference_id: PMID:11971963
          supporting_text: c-Abl tyrosine kinase regulates the human Rad9 
            checkpoint protein in response to DNA damage.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:11126360
    review:
      summary: Generic protein binding annotation.
      action: MODIFY
      reason: Per curation guidelines, protein binding is uninformative.
      proposed_replacement_terms:
        - id: GO:0051434
          label: BH3 domain binding
      supported_by:
        - reference_id: PMID:11126360
          supporting_text: A novel protein, RTN-XS, interacts with both Bcl-XL 
            and Bcl-2 on endoplasmic reticulum and reduces their anti-apoptotic 
            activity.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:12667443
    review:
      summary: Generic protein binding annotation.
      action: MODIFY
      reason: Per curation guidelines, protein binding is uninformative.
      proposed_replacement_terms:
        - id: GO:0051434
          label: BH3 domain binding
      supported_by:
        - reference_id: PMID:12667443
          supporting_text: p53 has a direct apoptogenic role at the 
            mitochondria.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:11054413
    review:
      summary: Generic protein binding annotation.
      action: MODIFY
      reason: Per curation guidelines, protein binding is uninformative.
      proposed_replacement_terms:
        - id: GO:0051434
          label: BH3 domain binding
      supported_by:
        - reference_id: PMID:11054413
          supporting_text: Oct 27. Bcl-G, a novel pro-apoptotic member of the 
            Bcl-2 family.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:11463391
    review:
      summary: Generic protein binding annotation.
      action: MODIFY
      reason: Per curation guidelines, protein binding is uninformative.
      proposed_replacement_terms:
        - id: GO:0051434
          label: BH3 domain binding
      supported_by:
        - reference_id: PMID:11463391
          supporting_text: PUMA induces the rapid apoptosis of colorectal cancer
            cells.
  - term:
      id: GO:0005741
      label: mitochondrial outer membrane
    evidence_type: NAS
    original_reference_id: PMID:12667443
    review:
      summary: MOM localization. Consistent with other annotations.
      action: ACCEPT
      reason: Valid core localization.
      supported_by:
        - reference_id: PMID:12667443
          supporting_text: p53 has a direct apoptogenic role at the 
            mitochondria.
  - term:
      id: GO:0005739
      label: mitochondrion
    evidence_type: TAS
    original_reference_id: PMID:10365962
    review:
      summary: Mitochondrial localization. Consistent with other annotations.
      action: ACCEPT
      reason: Valid core localization.
      supported_by:
        - reference_id: PMID:10365962
          supporting_text: Bcl-2 family proteins regulate the release of 
            apoptogenic cytochrome c by the mitochondrial channel VDAC.
  - term:
      id: GO:0008637
      label: apoptotic mitochondrial changes
    evidence_type: TAS
    original_reference_id: PMID:9393856
    review:
      summary: Bcl-xL is involved in apoptotic mitochondrial changes as a 
        negative regulator. It prevents the mitochondrial changes (cytochrome c 
        release, membrane potential loss) that occur during apoptosis.
      action: ACCEPT
      reason: Core function. Bcl-xL regulates the mitochondrial events of 
        apoptosis, specifically by preventing MOMP and downstream changes.
      supported_by:
        - reference_id: PMID:9393856
          supporting_text: Bcl-xL regulates the membrane potential and volume 
            homeostasis of mitochondria.
references:
  - id: GO_REF:0000002
    title: Gene Ontology annotation through association of InterPro records with
      GO terms
    findings: []
  - id: GO_REF:0000033
    title: Annotation inferences using phylogenetic trees
    findings: []
  - id: GO_REF:0000043
    title: Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword 
      mapping
    findings: []
  - id: GO_REF:0000044
    title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular 
      Location vocabulary mapping, accompanied by conservative changes to GO 
      terms applied by UniProt
    findings: []
  - id: GO_REF:0000107
    title: Automatic transfer of experimentally verified manual GO annotation 
      data to orthologs using Ensembl Compara
    findings: []
  - id: GO_REF:0000108
    title: Automatic assignment of GO terms using logical inference, based on on
      inter-ontology links
    findings: []
  - id: GO_REF:0000117
    title: Electronic Gene Ontology annotations created by ARBA machine learning
      models
    findings: []
  - id: GO_REF:0000120
    title: Combined Automated Annotation using Multiple IEA Methods
    findings: []
  - id: PMID:10365962
    title: Bcl-2 family proteins regulate the release of apoptogenic cytochrome 
      c by the mitochondrial channel VDAC.
    findings: []
  - id: PMID:10446169
    title: Interaction of Alzheimer's presenilin-1 and presenilin-2 with 
      Bcl-X(L). A potential role in modulating the threshold of cell death.
    findings: []
  - id: PMID:10837489
    title: MCL-1S, a splicing variant of the antiapoptotic BCL-2 family member 
      MCL-1, encodes a proapoptotic protein possessing only the BH3 domain.
    findings: []
  - id: PMID:11054413
    title: Bcl-G, a novel pro-apoptotic member of the Bcl-2 family.
    findings: []
  - id: PMID:11060313
    title: MAP-1, a novel proapoptotic protein containing a BH3-like motif that 
      associates with Bax through its Bcl-2 homology domains.
    findings: []
  - id: PMID:11126360
    title: A novel protein, RTN-XS, interacts with both Bcl-XL and Bcl-2 on 
      endoplasmic reticulum and reduces their anti-apoptotic activity.
    findings: []
  - id: PMID:11278245
    title: Bcl-B, a novel Bcl-2 family member that differentially binds and 
      regulates Bax and Bak.
    findings: []
  - id: PMID:11463391
    title: PUMA induces the rapid apoptosis of colorectal cancer cells.
    findings: []
  - id: PMID:11583631
    title: BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- 
      and BAK-mediated mitochondrial apoptosis.
    findings: []
  - id: PMID:11714801
    title: The association of Aiolos transcription factor and Bcl-xL is involved
      in the control of apoptosis.
    findings: []
  - id: PMID:11971963
    title: c-Abl tyrosine kinase regulates the human Rad9 checkpoint protein in 
      response to DNA damage.
    findings: []
  - id: PMID:12011449
    title: Siva-1 binds to and inhibits BCL-X(L)-mediated protection against UV 
      radiation-induced apoptosis.
    findings: []
  - id: PMID:12667443
    title: p53 has a direct apoptogenic role at the mitochondria.
    findings: []
  - id: PMID:12815463
    title: HSpin1, a transmembrane protein interacting with Bcl-2/Bcl-xL, 
      induces a caspase-independent autophagic cell death.
    findings: []
  - id: PMID:14739602
    title: The Siva-1 putative amphipathic helical region (SAH) is sufficient to
      bind to BCL-XL and sensitize cells to UV radiation induced apoptosis.
    findings: []
  - id: PMID:14752512
    title: Human alphaA- and alphaB-crystallins bind to Bax and Bcl-X(S) to 
      sequester their translocation during staurosporine-induced apoptosis.
    findings: []
  - id: PMID:15110758
    title: FAST is a BCL-X(L)-associated mitochondrial protein.
    findings: []
  - id: PMID:16189514
    title: Towards a proteome-scale map of the human protein-protein interaction
      network.
    findings: []
  - id: PMID:16608847
    title: PUMA Dissociates Bax and Bcl-X(L) to induce apoptosis in colon cancer
      cells.
    findings: []
  - id: PMID:16697956
    title: Mitochondria primed by death signals determine cellular addiction to 
      antiapoptotic BCL-2 family members.
    findings: []
  - id: PMID:17418785
    title: Bcl-2 and Bcl-XL regulate proinflammatory caspase-1 activation by 
      interaction with NALP1.
    findings: []
  - id: PMID:17428862
    title: Induction of apoptosis by the severe acute respiratory syndrome 
      coronavirus 7a protein is dependent on its interaction with the Bcl-XL 
      protein.
    findings: []
  - id: PMID:17525735
    title: ERK1/2-dependent phosphorylation of BimEL promotes its rapid 
      dissociation from Mcl-1 and Bcl-xL.
    findings: []
  - id: PMID:19060904
    title: An empirical framework for binary interactome mapping.
    findings: []
  - id: PMID:19180116
    title: DAP-kinase-mediated phosphorylation on the BH3 domain of beclin 1 
      promotes dissociation of beclin 1 from Bcl-XL and induction of autophagy.
    findings: []
  - id: PMID:19427857
    title: Transcriptomic and proteomic approach to studying SNX-2112-induced 
      K562 cells apoptosis and anti-leukemia activity in K562-NOD/SCID mice.
    findings: []
  - id: PMID:20010695
    title: Antagonism of Beclin 1-dependent autophagy by BCL-2 at the 
      endoplasmic reticulum requires NAF-1.
    findings: []
  - id: PMID:20541605
    title: RACK1 promotes Bax oligomerization and dissociates the interaction of
      Bax and Bcl-XL.
    findings: []
  - id: PMID:20673843
    title: Regulation of cell death in human fetal and adult ovaries--role of 
      Bok and Bcl-X(L).
    findings: []
  - id: PMID:21041309
    title: BH3 domains other than Bim and Bid can directly activate Bax/Bak.
    findings: []
  - id: PMID:21081150
    title: Pore-forming activity of BAD is regulated by specific phosphorylation
      and structural transitions of the C-terminal part.
    findings: []
  - id: PMID:21199865
    title: Mutation to Bax beyond the BH3 domain disrupts interactions with 
      pro-survival proteins and promotes apoptosis.
    findings: []
  - id: PMID:21639858
    title: Structural changes in the BH3 domain of SOUL protein upon interaction
      with the anti-apoptotic protein Bcl-xL.
    findings: []
  - id: PMID:21840391
    title: Bcl-xL phosphorylation at Ser49 by polo kinase 3 during cell cycle 
      progression and checkpoints.
    findings: []
  - id: PMID:21856303
    title: Protein oligomerization mediated by the transmembrane carboxyl 
      terminal domain of Bcl-XL.
    findings: []
  - id: PMID:21988832
    title: Toward an understanding of the protein interaction network of the 
      human liver.
    findings: []
  - id: PMID:22498477
    title: The anti-apoptotic Bcl-B protein inhibits BECN1-dependent autophagic 
      cell death.
    findings: []
  - id: PMID:25241761
    title: Using an in situ proximity ligation assay to systematically profile 
      endogenous protein-protein interactions in a pathway network.
    findings: []
  - id: PMID:25296756
    title: Plasminogen kringle 5 induces endothelial cell apoptosis by 
      triggering a voltage-dependent anion channel 1 (VDAC1) positive feedback 
      loop.
    findings: []
  - id: PMID:25416956
    title: A proteome-scale map of the human interactome network.
    findings: []
  - id: PMID:26582200
    title: Lifeguard Inhibits Fas Ligand-mediated Endoplasmic Reticulum-Calcium 
      Release Mandatory for Apoptosis in Type II Apoptotic Cells.
    findings: []
  - id: PMID:26871637
    title: Widespread Expansion of Protein Interaction Capabilities by 
      Alternative Splicing.
    findings: []
  - id: PMID:27013495
    title: The deubiquitinase Usp27x stabilizes the BH3-only protein Bim and 
      enhances apoptosis.
    findings: []
  - id: PMID:27107012
    title: Pooled-matrix protein interaction screens using Barcode Fusion 
      Genetics.
    findings: []
  - id: PMID:29507230
    title: Transmembrane E3 ligase RNF183 mediates ER stress-induced apoptosis 
      by degrading Bcl-xL.
    findings: []
  - id: PMID:29997244
    title: 'LuTHy: a double-readout bioluminescence-based two-hybrid technology for
      quantitative mapping of protein-protein interactions in mammalian cells.'
    findings: []
  - id: PMID:31467278
    title: Maximizing binary interactome mapping with a minimal number of 
      assays.
    findings: []
  - id: PMID:31515488
    title: Extensive disruption of protein interactions by genetic variants 
      across the allele frequency spectrum in human populations.
    findings: []
  - id: PMID:31980649
    title: Extensive rewiring of the EGFR network in colorectal cancer cells 
      expressing transforming levels of KRAS(G13D).
    findings: []
  - id: PMID:32296183
    title: A reference map of the human binary protein interactome.
    findings: []
  - id: PMID:32814053
    title: Interactome Mapping Provides a Network of Neurodegenerative Disease 
      Proteins and Uncovers Widespread Protein Aggregation in Affected Brains.
    findings: []
  - id: PMID:33961781
    title: Dual proteome-scale networks reveal cell-specific remodeling of the 
      human interactome.
    findings: []
  - id: PMID:34800366
    title: Quantitative high-confidence human mitochondrial proteome and its 
      dynamics in cellular context.
    findings: []
  - id: PMID:35512704
    title: Systematic discovery of mutation-directed neo-protein-protein 
      interactions in cancer.
    findings: []
  - id: PMID:37398436
    title: AI-guided pipeline for protein-protein interaction drug discovery 
      identifies a SARS-CoV-2 inhibitor.
    findings: []
  - id: PMID:40205054
    title: Multimodal cell maps as a foundation for structural and functional 
      genomics.
    findings: []
  - id: PMID:7650367
    title: Expression of Bcl-2, Bcl-x, and Bax after T cell activation and IL-2 
      withdrawal.
    findings: []
  - id: PMID:8358789
    title: bcl-x, a bcl-2-related gene that functions as a dominant regulator of
      apoptotic cell death.
    findings: []
  - id: PMID:9184696
    title: The apoptosis and proliferation of SAC-activated B cells by IL-10 are
      associated with changes in Bcl-2, Bcl-xL, and Mcl-1 expression.
    findings: []
  - id: PMID:9305851
    title: BH3 domain of BAD is required for heterodimerization with BCL-XL and 
      pro-apoptotic activity.
    findings: []
  - id: PMID:9388232
    title: Dimerization properties of human BAD. Identification of a BH-3 domain
      and analysis of its binding to mutant BCL-2 and BCL-XL proteins.
    findings: []
  - id: PMID:9393856
    title: Bcl-xL regulates the membrane potential and volume homeostasis of 
      mitochondria.
    findings: []
  - id: PMID:9843949
    title: Bax interacts with the permeability transition pore to induce 
      permeability transition and cytochrome c release in isolated mitochondria.
    findings: []
  - id: Reactome:R-HSA-508162
    title: BH3 only proteins associate with and inactivate anti-apoptotic BCL-XL
    findings: []
  - id: Reactome:R-HSA-6790025
    title: Expression of BCL2, BCL2L1
    findings: []
  - id: Reactome:R-HSA-879201
    title: Bcl-2 and Bcl-XL bind NLRP1
    findings: []
  - id: Reactome:R-HSA-9653595
    title: pS181-S-Farn-Me KRAS4B binds BCL2L1
    findings: []
  - id: Reactome:R-HSA-9698026
    title: FLT3 ITD- and STAT5-dependent BCL2L1 gene expression
    findings: []
  - id: Reactome:R-HSA-9704655
    title: SARS-CoV-1 E binds BCL2L1
    findings: []
  - id: Reactome:R-HSA-9704692
    title: SARS-CoV-1 7a binds BCL2L1
    findings: []
  - id: Reactome:R-HSA-9796043
    title: NFE2L2 dependent BCL2L1 expression
    findings: []
  - id: file:human/BCL2L1/BCL2L1-deep-research-perplexity.md
    title: Deep research report on BCL2L1
    findings: []
core_functions:
  - molecular_function:
      id: GO:0051434
      label: BH3 domain binding
    directly_involved_in:
      - id: GO:0043066
        label: negative regulation of apoptotic process
    locations:
      - id: GO:0005741
        label: mitochondrial outer membrane
    description: 'The CORE molecular function of Bcl-xL (canonical isoform Q07817-1).
      Bcl-xL contains a BH3-binding groove that binds the BH3 domains of pro-apoptotic
      proteins including BAX, BAK, BAD, BIM, PUMA, and NOXA. This binding sequesters
      pro-apoptotic proteins at the mitochondrial outer membrane and prevents their
      activation of the apoptotic cascade. Structural studies have characterized the
      BH3-binding groove at atomic resolution (PMID:21199865, PMID:21639858). As established
      in the foundational paper PMID:8358789, bcl-xL inhibits cell death upon growth
      factor withdrawal. By preventing BAX/BAK pore formation at the MOM, Bcl-xL inhibits
      cytochrome c release and blocks apoptosis. CRITICAL ISOFORM NOTE: BCL2L1 produces
      two antagonistic isoforms through alternative splicing. Bcl-xL (Q07817-1, 233
      AA) is ANTI-apoptotic (this core function). Bcl-xS (Q07817-2, 166 AA) lacks
      the BH1 and BH2 domains and is PRO-apoptotic.'
alternative_products:
  - name: Bcl-X(L) (Bcl-xL)
    id: Q07817-1
    description: >-
      The dominant anti-apoptotic isoform (233 AA). Contains all four BH domains (BH1-4)
      and inhibits apoptosis by sequestering pro-apoptotic BAX/BAK, preventing mitochondrial
      outer membrane permeabilization. Also regulates ATP synthase efficiency, calcium
      signaling, and autophagy. Most GO annotations for BCL2L1 refer to this isoform.
  - name: Bcl-X(S) (Bcl-xS)
    id: Q07817-2
    sequence_note: VSP_000515
    description: >-
      The pro-apoptotic short isoform (166 AA). Lacks BH1 and BH2 domains due to alternative
      5' splice site selection in exon 2. Promotes apoptosis by heterodimerizing with
      Bcl-xL
      and antagonizing its anti-apoptotic function. The Bcl-xL/Bcl-xS ratio determines
      cellular sensitivity to apoptotic stimuli. Annotations for "positive regulation
      of
      apoptotic process" likely reflect this isoform's function.
  - name: Bcl-X(beta)
    id: Q07817-3
    sequence_note: VSP_000516
    description: >-
      A less characterized isoform. Contains an alternative C-terminus compared to
      Bcl-xL.
      Functional studies are limited compared to Bcl-xL and Bcl-xS.

BCL2L1

Gene Description